Clinical Trials - ABBV

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT07155174A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung CancerNOT_YET_RECRUITINGPHASE2, PHASE32025-12-062031-092031-09
NCT07196644A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab AdizutecanNOT_YET_RECRUITINGPHASE22025-11-252030-122030-12
NCT07155187A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerNOT_YET_RECRUITINGPHASE2, PHASE32025-11-152031-082031-08
NCT07095452A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantNOT_YET_RECRUITINGPHASE2, PHASE32025-11-122042-012042-01
NCT07207369A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne ScarsNOT_YET_RECRUITINGPHASE32025-10-162029-112029-11
NCT06953934A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male ParticipantsNOT_YET_RECRUITINGPHASE12025-10-142026-022026-02
NCT07186595A Study to Evaluate the Safety and Effectiveness of JUVÉDERM Products in Adult Participants for the Change of Their Overall Facial AppearanceNOT_YET_RECRUITINGPHASE42025-09-232026-082026-08
NCT07007065Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)NOT_YET_RECRUITINGPHASE32025-09-172033-032033-03
NCT05316220A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative ColitisWITHDRAWNPHASE32025-09-152026-07-192026-07-19
NCT07059845A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian CancerNOT_YET_RECRUITINGPHASE22025-09-082029-012029-01
NCT07141199A Study to Evaluate Adverse Events, How the Drug is Tolerated, and How the Drug Moves Through the Body of Intravenous Infusions of ABBV-8736 in Adult Healthy VolunteersRECRUITINGPHASE12025-09-022026-042026-04
NCT06977724A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)RECRUITINGPHASE12025-08-262029-032029-03
NCT07024797Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese ParticipantsRECRUITINGPHASE12025-08-212026-032026-03
NCT06890338A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.NOT_YET_RECRUITINGPHASE22025-08-202029-102029-10
NCT07136103A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of ABBV-277 in Healthy Adult ParticipantsRECRUITINGPHASE12025-08-192026-052026-05
NCT07160179Study to Assess the Adverse Events and How Intravitreal ABBV-6628 Moves Through the Body of Adult Participants With Geographic Atrophy Secondary to Age-Related Macular DegenerationRECRUITINGPHASE1, PHASE22025-08-132029-102029-10
NCT07023289A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of DiseaseRECRUITINGPHASE22025-08-072029-112029-11
NCT06896916Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaRECRUITINGPHASE12025-08-072036-032036-03
NCT07145918A Study to Assess Adverse Events, Change in Disease Activity, and How Oral Emraclidine Moves Through the Body in Adult Participants With SchizophreniaRECRUITINGPHASE22025-08-042028-022028-02
NCT07005102A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerRECRUITINGPHASE2, PHASE32025-08-032031-122031-12
NCT07024784A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesRECRUITINGPHASE22025-07-302028-022028-01
NCT07071519A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative ColitisRECRUITINGPHASE32025-07-282034-072034-07
NCT07044687Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in IndiaRECRUITINGPHASE42025-07-242027-112027-11
NCT06953960A Study to Assess Adverse Events and Change in Disease Activity of Oral ABBV-453 Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)RECRUITINGPHASE1, PHASE22025-07-232030-122030-12
NCT07122583A Study to Assess Non-Invasive Subcutaneous Fat Reduction in the Submental, Inner Thigh and Back/Bra Areas With the CoolSculpting Elite SystemRECRUITINGPHASE42025-07-222026-082026-08
NCT07071532A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Healthy Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-07-152025-112025-11
NCT06892522A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; CarfilzomibRECRUITINGPHASE1, PHASE22025-06-302036-032036-02
NCT06972446A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisRECRUITINGPHASE22025-06-202027-112027-02
NCT07023302A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants in Japan With Alopecia AreataRECRUITINGPHASE32025-06-192029-022029-02
NCT06880744A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to VedolizumabRECRUITINGPHASE32025-06-172028-092028-09
NCT07007091A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administrations With a Pre-Filled Syringe or an On-Body Injector in Healthy Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-06-122025-122025-11
NCT06902558A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)RECRUITINGPHASE22025-06-092029-082029-08
NCT06682988A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab SoravtansineRECRUITINGPHASE22025-05-282028-032028-03
NCT07032597A Study to Assess Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Restoration and/or Creation of Mid-Face Volume in Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE32025-05-262026-102026-08
NCT06696755A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderNOT_YET_RECRUITINGPHASE22025-05-152026-10-292026-10-29
NCT06946524A Study to Assess the Bioavailability of Risankizumab Following Subcutaneous Administration With Prefilled Pen Relative to a Prefilled Syringe in Healthy Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-05-082026-012026-01
NCT06846320Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderRECRUITINGPHASE22025-04-292026-112026-11
NCT06820463A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal CancerRECRUITINGPHASE22025-04-242028-042028-03
NCT06937619A Study to Assess the Relative Bioavailability of Risankizumab Following Subcutaneous Administration With On-Body Injector in Healthy Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-04-212025-112025-11
NCT06858813A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)RECRUITINGPHASE12025-04-142030-092030-09
NCT06865105Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic ArthritisRECRUITINGPHASE22025-04-112028-012028-01
NCT06895343A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single Ascending Subcutaneous Doses of ABBV-701 in Healthy Adult Western and Asian ParticipantsRECRUITINGPHASE12025-04-032026-102026-10
NCT06895356A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult ParticipantsCOMPLETEDPHASE12025-03-262025-06-162025-06-16
NCT06887010A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult ParticipantsCOMPLETEDPHASE12025-03-252025-09-162025-09-16
NCT06772623Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsRECRUITINGPHASE1, PHASE22025-03-062027-112027-11
NCT06849791A Study to Assess the Relative Bioavailability of Oral ABBV-932 in Healthy Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE12025-02-262025-122025-11
NCT06834789A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)ACTIVE_NOT_RECRUITINGPHASE12025-02-182025-122025-12
NCT06810505A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 YearsRECRUITINGPHASE32025-02-132031-032031-03
NCT06822738A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With GlaucomaRECRUITINGPHASE32025-02-112028-112028-11
NCT06806293Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual MigraineRECRUITINGPHASE32025-02-102027-072027-02
NCT06291220A Study Assessing Adverse Event and How Oral ABBV-453 Moves Through the Body in Adult Participants With Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)ACTIVE_NOT_RECRUITINGPHASE12025-01-272029-072029-07
NCT06794866A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE32025-01-222026-042026-04
NCT06774313A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult ParticipantsRECRUITINGPHASE12025-01-222025-122025-12
NCT06568939A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)RECRUITINGPHASE22025-01-202028-022028-02
NCT06632951Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)ACTIVE_NOT_RECRUITINGPHASE22025-01-202028-082027-03
NCT06667687Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaRECRUITINGPHASE12025-01-162031-112031-11
NCT06783621A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica ProductsRECRUITINGPHASE42025-01-162026-072026-07
NCT06701331Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Children From 2 to Less Than 12 Years of Age in Japan With Moderate to Severe Atopic DermatitisRECRUITINGPHASE32024-12-222027-012027-01
NCT06718101A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic DermatitisRECRUITINGPHASE22024-12-192027-052027-05
NCT06742086A Study to Evaluate the Bioavailability and Food Effects of Oral Venetoclax New Tablet Formulation 2.0 in Healthy Adult Female ParticipantsRECRUITINGPHASE12024-12-192025-092025-09
NCT06734351A Study to Assess Safety and Effectiveness of Injections of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Change of Mid-Face VolumeRECRUITINGPHASE32024-12-162029-072029-07
NCT06628310A Study to Evaluate the Adverse Events, Efficacy, and Optimal Dose of Intravenous (IV) ABBV-400 in Combination With IV Fluorouracil, Leucovorin, and Budigalimab in Adult Participants With Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, or Esophageal AdenocarcinomaRECRUITINGPHASE22024-12-132030-102030-10
NCT06078202A Study to Assess the Relative Bioavailability of Three Immediate-Release Tablet Formulations of ABBV-903 in Healthy Adult VolunteersWITHDRAWNPHASE12024-12-012025-01-312025-01-31
NCT06722417A Single Dose Study to Assess Adverse Events and How Oral Icalcaprant Moves Through the Body in Healthy Adult Japanese and Han Chinese ParticipantsCOMPLETEDPHASE12024-11-262025-01-172025-01-17
NCT06722430A Study to Assess Change in How Oral Icalcaprant With Itraconazole Moves Through the Body in Healthy Adult ParticipantsCOMPLETEDPHASE12024-11-132025-01-132025-01-13
NCT06698926A Study to Assess the Safety, Tolerability, and Interactions of ABBV-CLS-616 Oral Tablets in Healthy Adult ParticipantsRECRUITINGPHASE12024-11-112025-122025-12
NCT06614192A Study Assessing Adverse Events and Disease Activity When Comparing Intravenously (IV) Infused ABBV-400 to Trifluridine and Tipiracil (LONSURF) Oral Tablets Plus IV Infused Bevacizumab in Adult Participants With c-Met Protein Above Cutoff Level Above Refractory Metastatic Colorectal CancerRECRUITINGPHASE32024-11-082028-102028-10
NCT06575192Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix Breast Reconstruction (ADORA) in Adult ParticipantsRECRUITINGPHASE32024-11-052029-122029-12
NCT06673238A Study to Assess How the Drug Moves Through the Body, Adverse Events, and Tolerability of Oral ABBV-722 Capsules of Single and Multiple Ascending Doses in Adult Participants and Single Doses in Adult Asian ParticipantsRECRUITINGPHASE12024-10-292026-042026-04
NCT06618118A Study to Assess Adverse Events of Fosigotifator (ABBV-CLS-7262) in Adults With Major Depressive DisorderTERMINATEDPHASE12024-10-232025-09-232025-09-23
NCT06605599Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II DisorderRECRUITINGPHASE22024-10-152026-022026-01
NCT06632938A Study to Evaluate Adverse Events and How the Drug Moves Through the Body From Subcutaneous (SC) and Intravenous (IV) Doses of ABBV-382 in Healthy Adult Chinese VolunteersCOMPLETEDPHASE12024-10-082025-05-152025-05-15
NCT06602479A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic MigraineACTIVE_NOT_RECRUITINGPHASE22024-10-072025-09-152025-09-15
NCT06464692Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal CancerRECRUITINGPHASE1, PHASE22024-09-302028-092028-09
NCT06571266A Study to Assess the Relative Bioavailability of Two Formulations of Risankizumab Following Subcutaneous Administration With Prefilled Syringes in Healthy Adult ParticipantsCOMPLETEDPHASE12024-09-112025-04-162025-04-16
NCT06487559A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves Through the Bodies of Adult Chinese Participants With Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC)RECRUITINGPHASE12024-09-112027-102027-10
NCT06417775Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual MigraineRECRUITINGPHASE32024-09-102027-092027-06
NCT06579300A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088SUSPENDEDPHASE12024-09-042026-082026-08
NCT06548542Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's DiseaseRECRUITINGPHASE22024-09-042028-082027-12
NCT06300580Study of Oral ABBV-932 Capsules to Evaluate Dopamine D2 and D3 Receptor Occupancy in Brain in Adult Healthy VolunteersCOMPLETEDPHASE12024-08-212025-05-262025-05-26
NCT06461897A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic DermatitisRECRUITINGPHASE32024-08-192030-072030-07
NCT06524635A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabRECRUITINGPHASE22024-08-142027-022027-02
NCT06428019A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)RECRUITINGPHASE32024-08-052028-032028-03
NCT06365853A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha ExpressionRECRUITINGPHASE22024-07-292027-062026-06
NCT06332534Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE32024-07-262034-122027-06
NCT06487572A Study to Assess Pharmacokinetic Exposures Following Intravenous and Subcutaneous Administration of Risankizumab in Healthy ParticipantsCOMPLETEDPHASE12024-07-232025-02-072025-02-07
NCT06547125A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants For the Improvement of Skin QualityACTIVE_NOT_RECRUITINGPHASE2, PHASE32024-07-182026-022026-02
NCT06477926A Study to Assess Relative Bioavailability and Food Effect of ABBV-668 Extended-Release Formulations in Adult ParticipantsCOMPLETEDPHASE12024-07-092024-09-202024-09-20
NCT06100744A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabRECRUITINGPHASE32024-07-082028-102026-09
NCT06468228A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis SuppurativaRECRUITINGPHASE32024-06-272026-122026-12
NCT06402513A Study in Healthy Adult Participants to Assess the Pharmacokinetics, Immunogenicity, Safety, and Tolerability of a Ravagalimab Subcutaneous Formulation in a Pre-Filled SyringeCOMPLETEDPHASE12024-06-242024-10-082024-10-08
NCT06223516Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple MyelomaRECRUITINGPHASE12024-06-172027-022027-02
NCT06389136A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to DupilumabRECRUITINGPHASE32024-06-122027-032026-08
NCT06093503Study of Intravenous Telisotuzumab Vedotin in Combination Osimertinib or Standard of Care Chemotherapy to Assess Change in Disease Activity in Adult Participants With Non-Small Cell Lung Cancer That Has a Mutation in the Epidermal Growth Factor Receptor Gene and That Overexpresses the c-Met ProteinWITHDRAWNPHASE32024-05-312028-04-112028-04-11
NCT06390722A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic DermatitisWITHDRAWNPHASE32024-05-232026-07-082026-01-05
NCT06158841Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple MyelomaRECRUITINGPHASE32024-05-192027-122027-12
NCT06414798A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABBV-1088 Oral Dose in Healthy Adult Participants.COMPLETEDPHASE12024-05-132025-02-082025-02-08
NCT06333860A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body)ACTIVE_NOT_RECRUITINGPHASE42024-05-102026-032025-12
NCT06406348A Phase 1 Trial to Assess Safety, Tolerability and Pharmacokinetics of ALIA-1758 in Healthy ParticipantsCOMPLETEDPHASE12024-05-092025-04-222025-04-22
NCT05606757A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation TechniqueWITHDRAWNPHASE22024-05-072025-09-262025-04-22
NCT06399718A Study to Assess BOTOX Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE32024-04-302025-112025-11
NCT06345339A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult ParticipantsRECRUITINGPHASE2, PHASE32024-04-262028-062027-09
NCT06346288A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel DiseaseACTIVE_NOT_RECRUITINGPHASE42024-04-242026-02-062025-10-01
NCT06387394A Study to Assess BOTOX Injections in Adult Participants for the Change of Masseter Muscle ProminenceACTIVE_NOT_RECRUITINGPHASE32024-04-222025-112025-11
NCT06236438Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)RECRUITINGPHASE2, PHASE32024-04-102031-102031-10
NCT06158854A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) InfusionRECRUITINGPHASE1, PHASE22024-04-012028-022025-12
NCT06308198A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar LinesCOMPLETEDPHASE32024-03-292025-02-262025-02-26
NCT06241313Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With MigraineRECRUITINGPHASE32024-03-252026-112025-07-07
NCT06257875A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE22024-03-232027-092027-09
NCT06318273A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic Castration-Resistant Prostate CancerRECRUITINGPHASE12024-03-082027-052027-05
NCT06278766A Study to Assess the Mass Balance of [14C] ABBV-552 in Healthy Male Participants Following Single Oral Dose AdministrationCOMPLETEDPHASE12024-02-212024-04-192024-04-19
NCT06158958A Study to Assess the Safety, Pharmacokinetics, and Efficacy of Intravenous (IV) ABBV-303, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adults With Advanced Solid TumorsRECRUITINGPHASE12024-02-062028-012028-01
NCT06218251A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial LinesCOMPLETEDPHASE42024-02-052024-12-172024-07-25
NCT06148181A Study to Evaluate Adverse Events and How Single Ascending Doses of ABBV-141 Move Through the Body of Healthy Adult Western and Asian ParticipantsCOMPLETEDPHASE12024-01-292024-12-302024-12-30
NCT05956509Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb SpasticityTERMINATEDPHASE12024-01-122024-06-022024-06-02
NCT06109272A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)RECRUITINGPHASE2, PHASE32024-01-112030-092030-09
NCT06151561Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar LinesCOMPLETEDPHASE12024-01-052024-04-032024-04-03
NCT06118411A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With VitiligoACTIVE_NOT_RECRUITINGPHASE32023-12-192028-022025-10
NCT06151535A Study to Evaluate the Safety and Effectiveness of ELAPR002f Injectable Gel for the Improvement of Skin Quality in Adult ParticipantsCOMPLETEDPHASE22023-12-192025-02-242025-02-24
NCT06174688A Study to Assess the Adverse Events and Effectiveness of BOTOX Injections for the Treatment of Moderate to Severe Forehead Lines in Chinese Adult ParticipantsCOMPLETEDPHASE32023-12-122024-09-132024-09-13
NCT05995353A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE32023-12-112029-042029-04
NCT05821855A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in ChinaRECRUITINGPHASE42023-12-082030-072030-07
NCT06144684A Two-Part First-In-Human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB014295RECRUITINGPHASE12023-11-292026-042026-04
NCT06137287A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult ParticipantsCOMPLETEDPHASE32023-11-222025-07-312025-07-31
NCT05995340ELAPR002f Injectable Gel in the Treatment of Atrophic Acne ScarsACTIVE_NOT_RECRUITINGPHASE32023-11-212026-082026-08
NCT06054425A Study to Compare the Bioavailability of Intravenously Infused Risankizumab Manufactured by Two Different Processes in Healthy AdultsCOMPLETEDPHASE12023-11-202024-05-062024-05-06
NCT06063967A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.ACTIVE_NOT_RECRUITINGPHASE32023-11-152027-032027-03
NCT06068868Study to Evaluate Adverse Events and Movement of Intravenously (IV) Infused ABBV-787 in Adult Participants With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)TERMINATEDPHASE12023-11-132025-02-252025-02-25
NCT06107413Study to Assess Adverse Events and Change in Disease Activity in Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer in Combination With IV Fluorouracil, Folinic Acid, and BevacizumabRECRUITINGPHASE22023-11-122026-102026-10
NCT06084481Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400RECRUITINGPHASE12023-11-092026-072026-07
NCT05782907Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.RECRUITINGPHASE32023-11-062033-102028-08
NCT06068855A Study to Assess the Effectiveness of BOTOX (Botulinum Toxin Type A) Injections for the Change of Masseter Muscle Prominence in Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE32023-10-172025-112025-11
NCT06032546A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382COMPLETEDPHASE22023-10-122025-09-222025-09-22
NCT06012240A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia AreataRECRUITINGPHASE32023-10-112028-012028-01
NCT05748483Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With MigraineACTIVE_NOT_RECRUITINGPHASE32023-10-072026-052025-04-28
NCT06070948A Study to Assess Food Effect of Venetoclax New Tablet Formulation in Healthy Female ParticipantsWITHDRAWNPHASE12023-10-052025-07-282025-07-28
NCT05609630Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.RECRUITINGPHASE32023-10-022029-062029-06
NCT06067568Relative Bioavailability of Two Lutikizumab Formulations and Pharmacokinetics, Safety, and Tolerability of Lutikizumab in Chinese ParticipantsCOMPLETEDPHASE12023-09-282024-02-262024-02-26
NCT05822752Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)ACTIVE_NOT_RECRUITINGPHASE22023-09-212026-112026-11
NCT06018987A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial FoldsCOMPLETEDPHASE2, PHASE32023-09-052025-02-032025-02-03
NCT06024239A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)COMPLETEDPHASE12023-08-312025-03-042025-03-04
NCT06009237A Study to Assess Pharmacokinetics, Safety, and Tolerability of ABBV-903 in Healthy Japanese and Han Chinese ParticipantsTERMINATEDPHASE12023-08-232023-10-302023-10-30
NCT05995366A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose AdministrationCOMPLETEDPHASE12023-08-182023-10-132023-10-13
NCT05969223Study to Assess the Safety and Efficacy of Subcutaneously Injected Risankizumab in Adult Participants With Genital or Scalp PsoriasisACTIVE_NOT_RECRUITINGPHASE42023-08-102025-112025-01-22
NCT05941442A Study to Evaluate Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic DisorderCOMPLETEDPHASE22023-07-312025-03-312025-03-31
NCT05940402A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal FunctionCOMPLETEDPHASE12023-07-242024-12-192024-12-19
NCT05843643Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus ErythematosusRECRUITINGPHASE32023-07-192027-102026-12
NCT05861427Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic MigraineCOMPLETEDPHASE32023-07-122025-03-012025-03-01
NCT05892757Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult VolunteersCOMPLETEDPHASE12023-07-112024-02-222024-02-22
NCT05935033A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of EmraclidineCOMPLETEDPHASE12023-06-302025-02-212025-02-21
NCT05878067A Study to Assess Symptom Relief and Product Tolerability of ABBV-444 Drops in Adult ParticipantsCOMPLETEDPHASE32023-06-272023-10-062023-10-06
NCT05895266A Study to Assess Drug-Drug Interaction Between ABBV-903 and Midazolam in Adult Healthy VolunteersCOMPLETEDPHASE12023-06-232023-11-022023-11-02
NCT05889182A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF TherapyRECRUITINGPHASE32023-06-212028-032028-03
NCT05814627Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid ArthritisACTIVE_NOT_RECRUITINGPHASE32023-06-152026-082025-08
NCT05909553Study to Assess Adverse Events and Compare How Crushed, Ground, and Intact Oral Tablets Venetoclax Moves Through the Body of Healthy Female Adult VolunteersCOMPLETEDPHASE12023-06-152023-09-222023-09-22
NCT05818709A Study to Assess Adverse Events and Effectiveness of HAC 22L Injection for Mid-Face Volume in Adult ParticipantsACTIVE_NOT_RECRUITINGPHASE32023-06-142025-112025-11
NCT05753501Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell MalignanciesRECRUITINGPHASE12023-06-092031-032031-03
NCT05707949Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With MigraineENROLLING_BY_INVITATIONPHASE32023-06-052032-042032-04
NCT05507580A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE42023-05-292024-08-152024-07-11
NCT05711394A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineRECRUITINGPHASE32023-05-012028-052028-03
NCT05760313A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With LinaclotideCOMPLETEDPHASE22023-04-272025-06-092025-06-09
NCT05771428Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's DiseaseCOMPLETEDPHASE22023-04-272024-09-122024-08-06
NCT05512390A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)RECRUITINGPHASE12023-04-262027-022027-02
NCT05785715Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative ColitisTERMINATEDPHASE22023-04-242025-05-302025-05-30
NCT05836506A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult ParticipantsCOMPLETEDPHASE12023-04-182023-06-202023-06-20
NCT05741034A Study to Assess Adverse Events and Effectiveness of Injected JUVÉDERM® VOLITE™ Gel Filler for Change in Neck Lines in Adult Chinese ParticipantsCOMPLETEDPHASE32023-04-072024-12-092024-12-09
NCT05618028Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 TabletsRECRUITINGPHASE12023-04-042027-062027-06
NCT05650632A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple MyelomaRECRUITINGPHASE12023-03-212027-032027-03
NCT05570006Study of ABBV-668 Oral Capsules to Assess Adverse Events and Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative ColitisCOMPLETEDPHASE22023-03-162024-12-232024-12-23
NCT05757141An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter DiseaseRECRUITINGPHASE1, PHASE22023-03-132029-112027-11
NCT05738850Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult ParticipantsCOMPLETEDPHASE12023-02-152024-05-312024-05-31
NCT05686980A Study to Assess the Adverse Events and How Oral ABBV-552 Capsules Moves Through the Body of Healthy Adult Japanese and Han Chinese ParticipantsCOMPLETEDPHASE12023-01-172023-03-302023-03-30
NCT05527184First in Human Study of IMGN151 in Recurrent Gynaecological CancersRECRUITINGPHASE12023-01-112027-022027-02
NCT05647551A Study to Evaluate Satisfaction in Adult Participants With the Aesthetics of the Periorbital Area After JUVÉDERM® Fillers and BOTOX®/VISTABEL® InjectionsCOMPLETEDPHASE42023-01-052023-10-052023-10-05
NCT05691699A Study to Assess Adverse Events and How Single and Multiple Ascending Doses of ABBV-903 Move Through the Body in Healthy AdultsCOMPLETEDPHASE12023-01-032023-10-232023-10-23
NCT05652205A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional ConstipationCOMPLETEDPHASE32022-12-292025-09-022025-09-02
NCT05445778Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal CancerRECRUITINGPHASE32022-12-272029-042027-03
NCT05599984Study to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid TumorsRECRUITINGPHASE12022-12-052026-062026-06
NCT05644977A Multiple Dose Trial of Emraclidine in Elderly Participants and in Participants With Dementia Due to Alzheimer's DiseaseCOMPLETEDPHASE12022-12-022025-04-142025-04-14
NCT05601882A Study to Evaluate Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32022-11-282024-08-082024-03-19
NCT05513703A Study to Assess Disease Activity of Intravenously (IV) Infused Telisotuzumab Vedotin in Adult Participants With Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)TERMINATEDPHASE22022-11-212024-10-282024-10-28
NCT05259839A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused Etentamig (ABBV-383) in Combination With Anti-Cancer Regimens for the Treatment of Adult Participants With Relapsed/Refractory Multiple MyelomaRECRUITINGPHASE12022-10-202033-092033-09
NCT05556226Study to Assess Adverse Events and Compare How Two Subcutaneous ABBV-154 Injection Formulations Move Through the Body of Adult Healthy ParticipantsCOMPLETEDPHASE12022-10-182023-02-172023-02-17
NCT05456685Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian CancerACTIVE_NOT_RECRUITINGPHASE22022-09-282026-112026-11
NCT05567029Study to Evaluate the Relative Bioavailability of Two Risankizumab Drug Product Presentations in Healthy Volunteers.COMPLETEDPHASE12022-09-282023-04-202023-04-20
NCT05538585A Study to Assess How Food Affects the Safety and Pharmacokinetics of Galicaftor and NavocaftorCOMPLETEDPHASE12022-09-272022-12-212022-12-21
NCT05530278A Study to Assess the Pharmacokinetics and Safety of Co-administered Oral Galicaftor, Navocaftor, and ABBV-576 in Healthy Adults for the Treatment of Cystic FibrosisCOMPLETEDPHASE12022-09-202022-11-292022-11-29
NCT05454033A Study to Assess Adverse Events and Effectiveness of Intradermally Injected JUVÉDERM® VOLITE™ Gel Filler in Adult Participants in China With Fine Lines Around the MouthCOMPLETEDPHASE32022-09-072024-09-032024-09-03
NCT05443724A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaCOMPLETEDPHASE22022-09-022025-06-252025-06-25
NCT05496335A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar LinesCOMPLETEDPHASE12022-08-302023-05-302023-05-30
NCT05368558Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With SchizophreniaTERMINATEDPHASE32022-08-182024-09-202024-09-20
NCT05291234A Study to Assess Safety of ABBV-916 and How Intravenous ABBV-916 Moves Through Body and Affects Brain Amyloid Plaque Clearance in Adult Participants (Aged 50-90 Years) With Early Alzheimer's DiseaseACTIVE_NOT_RECRUITINGPHASE22022-08-152025-112025-11
NCT05475821Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy ParticipantsTERMINATEDPHASE12022-07-252022-09-262022-09-26
NCT05411198Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle GlaucomaRECRUITINGPHASE32022-07-222026-012026-01
NCT05414201A Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-UveitisCOMPLETEDPHASE42022-07-072024-06-102024-06-10
NCT05439616Study of Cariprazine Oral Capsules or Solution to Assess Adverse Events and Change in Irritability Due to Autism Spectrum Disorder (ASD) in Participants Aged 5-17 Years With ASDCOMPLETEDPHASE32022-07-072024-10-042024-10-04
NCT05376839A Study to Assess Safety of Cedirogant and How Cedirogant Moves Through the Body in Adult Participants With Mild, Moderate and Severe Hepatic ImpairmentTERMINATEDPHASE12022-07-062022-11-082022-11-08
NCT05227690A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With SchizophreniaCOMPLETEDPHASE22022-06-302024-08-262024-08-23
NCT05227703A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With SchizophreniaCOMPLETEDPHASE22022-06-302024-09-112024-08-15
NCT05308654A Study to Assess the Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple Myeloma Receiving Oral ABBV-453 TabletsACTIVE_NOT_RECRUITINGPHASE12022-05-172025-122024-02-07
NCT05316233A Study to Assess Adverse Events and Change in Disease Activity of JUVÉDERM® VOLITE™ XC Injectable Gel for Change in Neck Appearance in Adult ParticipantsCOMPLETEDPHASE32022-05-022024-09-122024-09-12
NCT05216250Study of BOTOX Injections to Assess Change in Disease Symptoms in Adult Participants With Upper Limb Essential TremorCOMPLETEDPHASE22022-04-122025-02-032025-02-03
NCT05141006Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)COMPLETEDPHASE22022-03-292024-12-062024-07-05
NCT04895436Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)RECRUITINGPHASE22022-03-282029-012026-11
NCT04928846A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)RECRUITINGPHASE32022-03-252028-032028-03
NCT05286229A Study to Assess Adverse Events and Change in Disease State of Intravenously (IV) Infused Etentamig (ABBV-383) of Adult Participants With Relapsed or Refractory Multiple Myeloma in JapanACTIVE_NOT_RECRUITINGPHASE12022-03-242026-032026-03
NCT05216263Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic MigraineCOMPLETEDPHASE32022-03-222025-05-022025-05-02
NCT05248867A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar LinesCOMPLETEDPHASE32022-03-162023-03-172023-03-17
NCT05264129Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With MigraineCOMPLETEDPHASE42022-03-072023-04-042023-04-04
NCT05248893A Study to Assess Adverse Events of Intramuscular AGN-151586 Injection in Adult Participants With Glabellar LinesCOMPLETEDPHASE32022-02-252023-06-262023-06-26
NCT05068284A Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Intravenous (IV) Infusion and Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Crohn's DiseaseTERMINATEDPHASE22022-01-312023-07-202023-07-20
NCT05094050Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's DiseaseCOMPLETEDPHASE12022-01-182023-03-172023-03-17
NCT04895410Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Lemzoparlimab With or Without Oral/IV Dexamethasone and in Combination With Oral/IV/Subcutaneous Anti-Myeloma Regimens in Adult Participants With Multiple MyelomaTERMINATEDPHASE12022-01-172022-06-242022-06-24
NCT05127954Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17)ENROLLING_BY_INVITATIONPHASE32022-01-142028-012028-01
NCT05125302Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)RECRUITINGPHASE32022-01-132026-052026-05
NCT05407636Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMDRECRUITINGPHASE32022-01-132027-112026-10
NCT05144243Study to Assess Adverse Events and Change in Disease State of Oral Venetoclax in Combination With Subcutaneous (SC) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Intensive Chemotherapy in ChinaACTIVE_NOT_RECRUITINGPHASE42022-01-062026-032026-03
NCT05139602A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are NaĂŻve to Biologic TherapyACTIVE_NOT_RECRUITINGPHASE22021-12-282026-012026-01
NCT05134649A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma ProminenceCOMPLETEDPHASE32021-11-162023-08-182023-08-18
NCT05044234A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe PsoriasisTERMINATEDPHASE22021-11-162022-11-302022-11-30
NCT03400306A Study Evaluating the Bioavailability and Food Effect of Veliparib Tablets Followed by an Extension in Subjects With Ovarian CancerWITHDRAWNPHASE12021-11-152021-11-162021-11-16
NCT05105841Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax in Combination With Intravenous (IV) Obinutuzumab or Oral Ibrutinib in Adult Participants With Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)ACTIVE_NOT_RECRUITINGPHASE22021-11-082025-112025-11
NCT05028569Study of BOTOX Injections in Prevention of Migraine in Adult Participants With Episodic MigraineCOMPLETEDPHASE32021-11-052024-11-062024-11-06
NCT05005403Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or BevacizumabRECRUITINGPHASE12021-11-012027-062026-07
NCT05069597Study to Evaluate Symptoms of Exocrine Pancreatic Insufficiency in Adult Participants With Cystic Fibrosis or Chronic Pancreatitis Treated With CreonCOMPLETEDPHASE42021-10-142023-08-282023-07-07
NCT05029882Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV BevacizumabACTIVE_NOT_RECRUITINGPHASE12021-10-132027-112027-11
NCT04976777A Study to Evaluate an Updated Dexamethasone Intravitreal (Into the Eye) Applicator in Adult Participants With Macular Edema Due to Diseases of the RetinaCOMPLETEDPHASE32021-10-122022-02-092022-02-09
NCT04948645A Phase 1 Study to Investigate the Safety and Pharmacokinetics of Fosigotifator in Patients With Amyotrophic Lateral SclerosisTERMINATEDPHASE12021-09-222025-07-152025-07-15
NCT04853368Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic FibrosisTERMINATEDPHASE22021-09-202023-06-052023-06-05
NCT04972968A Study to Evaluate the Change in Disease State and Adverse Events in Adult Participants With Polymyalgia Rheumatica (PMR) Dependent on Glucocorticoid Treatment, Receiving Subcutaneous Injections of ABBV-154TERMINATEDPHASE22021-09-092023-07-242023-07-24
NCT05041257Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers (PICCOLO)COMPLETEDPHASE22021-08-312024-12-122024-01-17
NCT04903626Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)COMPLETEDPHASE32021-08-242024-09-172024-09-17
NCT04965272A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response to ADTs AloneWITHDRAWNPHASE22021-08-182021-08-242021-08-24
NCT04880876A Study Evaluating Oral Eluxadoline Administered to Pediatric Participants With Irritable Bowel Syndrome With Diarrhea (IBS-D)ENROLLING_BY_INVITATIONPHASE32021-08-132032-122032-12
NCT04994535A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma ProminenceCOMPLETEDPHASE32021-08-102023-06-142023-06-14
NCT04862286Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977ACTIVE_NOT_RECRUITINGPHASE32021-07-242028-042028-04
NCT04949399A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma ProminenceCOMPLETEDPHASE32021-07-082022-12-202022-12-20
NCT04810598Study to Assess Adverse Events and the Movement of Oral Venetoclax Tablet Through the Body of Female Participants Aged 18-75 Years With Impaired Renal FunctionCOMPLETEDPHASE12021-07-082022-08-162022-08-16
NCT04927975Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental VitiligoCOMPLETEDPHASE22021-06-302023-08-292023-01-13
NCT04912063Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic SyndromeTERMINATEDPHASE12021-06-252023-05-092023-05-09
NCT04888585Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)TERMINATEDPHASE22021-06-232023-08-042022-08-25
NCT04958031A Trial of the Safety, Tolerability, and Pharmacodynamics of CVL-871 in Subjects With Dementia-Related ApathyCOMPLETEDPHASE22021-06-222025-02-132025-02-13
NCT04908475Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic TherapyCOMPLETEDPHASE42021-06-092023-04-202023-04-20
NCT04807972Study to Evaluate Adverse Events and Change in Disease Activity When Intravenous (IV) Infusion of ABBV-927 is Administered in Combination With IV Modified FOLFIRINOX (mFFX) With or Without IV Budigalimab Compared to mFFX in Adult Participants With Untreated Pancreatic Cancer MetastasisTERMINATEDPHASE12021-05-282024-03-252024-03-25
NCT04913610Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus InfectionTERMINATEDPHASE22021-05-222023-08-292023-08-29
NCT04837482A Study to Assess the Impact and Adverse Events of Topical Eyedrops of AGN-190584 on Night-driving Performance in Participants, 40 to 55 Years of AgeCOMPLETEDPHASE32021-05-142021-12-072021-12-07
NCT04777357A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.RECRUITINGPHASE32021-04-282027-032027-03
NCT04804254Study to Evaluate Adverse Events, Change in Disease Activity, Movement of Oral ABBV-623 and ABBV-992 Tablets in the Body of Adult Participants With B-cell CancersTERMINATEDPHASE12021-04-272023-01-112023-01-11
NCT04554966Study to Assess Adverse Events and How Intravenous (IV) or Subcutaneous (SC) ABBV-382 Moves Through the Body of Adult Participants With Human Immuno-Deficiency Virus (HIV-1)COMPLETEDPHASE12021-04-162023-08-142023-08-14
NCT04480086Safety and Tolerability Study of Mivebresib Tablet Alone or in Combination With Ruxolitinib Tablet or Navitoclax Tablet in Adult Participants With MyelofibrosisTERMINATEDPHASE12021-03-172023-07-282023-07-28
NCT04818515Study To Assess Adverse Events and Drug to Drug Interaction of Oral Tablet Atogepant and Ubrogepant in Adult Participants With a History of MigraineCOMPLETEDPHASE12021-03-172021-06-182021-06-18
NCT04799353Study to Evaluate the Safety and How the Body Handles a Single Dose of Subcutaneous (SC) and Intravenous (IV) Budigalimab in Adult Participants Living With Human Immunodeficiency Virus (HIV)COMPLETEDPHASE12021-03-152022-10-112022-10-11
NCT04777994Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsRECRUITINGPHASE12021-03-092026-102026-10
NCT04713592Study of Subcutaneous (Injected Under the Skin) Risankizumab to Assess Change in Disease Symptoms in Adult Participants With Moderate to Severe Plaque Psoriasis With Palmoplantar InvolvementCOMPLETEDPHASE32021-02-262023-04-202023-04-20
NCT04760769Open-label Trial in Parkinson's Disease (PD)ACTIVE_NOT_RECRUITINGPHASE32021-02-242026-012026-01
NCT04721015Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid TumorsACTIVE_NOT_RECRUITINGPHASE12021-02-232026-022026-02
NCT04832724RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)COMPLETEDPHASE22021-02-222024-03-182023-10-02
NCT04686136A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic MigraineACTIVE_NOT_RECRUITINGPHASE32021-02-192025-10-082025-10-08
NCT04750226Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseACTIVE_NOT_RECRUITINGPHASE32021-02-182026-042026-04
NCT04578756Open-Label, Flexible-dose Study to Evaluate the Long-Term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants With Schizophrenia, Bipolar I Disorder, or Autism Spectrum DisorderACTIVE_NOT_RECRUITINGPHASE32021-02-012025-102025-10
NCT04704921Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMDRECRUITINGPHASE2, PHASE32020-12-292027-112026-12
NCT04666675A Study of Oral Upadacitinib Tablets to Assess Change in Disease State in Participants Aged 12-75 Years With Moderate to Severe Atopic Dermatitis in BrazilWITHDRAWNPHASE32020-12-242021-03-232021-03-23
NCT04644120Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)COMPLETEDPHASE12020-12-102021-08-242021-08-24
NCT04686786An Open-label Extension Trial of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresCOMPLETEDPHASE22020-12-082024-12-052024-12-05
NCT04567550RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)ACTIVE_NOT_RECRUITINGPHASE22020-11-202026-122026-06
NCT04499248AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular HypertensionRECRUITINGPHASE1, PHASE22020-11-162029-022029-02
NCT04454658Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With MyelofibrosisACTIVE_NOT_RECRUITINGPHASE12020-11-112027-012027-01
NCT04309474A Safety and Efficacy Study of Intravenous (IV) Elezanumab Assessing Change in Neurologic Function in Adult Participants With Acute Ischemic StrokeCOMPLETEDPHASE22020-11-092024-12-232024-04-18
NCT04570631Study to Determine Recommended Phase 2 Dose of Intravenous (IV) Eftozanermin Alfa in Combination With IV or Subcutaneous (SC) Bortezomib and Oral Dexamethasone Tablet and to Assess Change in Disease Symptoms in Adult Participants With Relapsed or Refractory Multiple MyelomaTERMINATEDPHASE12020-11-052025-05-052025-05-05
NCT04380142Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseCOMPLETEDPHASE32020-10-192021-09-292021-09-29
NCT04509622A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)COMPLETEDPHASE32020-10-052021-04-152021-04-15
NCT04524611Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)ACTIVE_NOT_RECRUITINGPHASE32020-09-302028-022028-02
NCT04472598Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With MyelofibrosisCOMPLETEDPHASE32020-09-292025-01-292023-04-13
NCT04542499Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)COMPLETEDPHASE32020-09-232024-02-152024-01-29
NCT04477486Study to Assess Effect of Oral Venetoclax Tablet in Combination With Oral Ibrutinib Capsule on Best Overall Response of Complete Response in Adult Japanese Participants With Relapsed/Refractory Mantle Cell LymphomaCOMPLETEDPHASE22020-09-232025-05-282022-02-09
NCT04064827A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)ACTIVE_NOT_RECRUITINGPHASE32020-09-162027-032026-11
NCT05274087Study to Evaluate the Effect of Different Warm-Up Times of Risankizumab Autoinjector (AI) on the Injection Pain Experiences in Healthy VolunteersCOMPLETEDPHASE12020-09-152021-04-072021-04-07
NCT04401748Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic SyndromeACTIVE_NOT_RECRUITINGPHASE32020-09-102026-032026-03
NCT04295538Safety And Efficacy Study Of Intravenous (IV) Administration Of Elezanumab To Assess Change In Upper Extremity Motor Score (UEMS) In Adult Participants With Acute Traumatic Cervical Spinal Cord Injury (SCI)ACTIVE_NOT_RECRUITINGPHASE22020-09-062026-012026-01
NCT05274100Study of Intravenous and Subcutaneous Administration of Risankizumab in Healthy ParticipantsCOMPLETEDPHASE12020-09-012021-07-062021-07-06
NCT04468984Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory MyelofibrosisACTIVE_NOT_RECRUITINGPHASE32020-08-312026-122025-01-29
NCT04514653RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)RECRUITINGPHASE22020-08-252026-08-012025-10-21
NCT04492020Study to Evaluate Oral Ubrogepant in the Acute Treatment of Migraine During the Prodrome in Adult ParticipantsCOMPLETEDPHASE32020-08-212022-04-192022-04-19
NCT04333576Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe PainRECRUITINGPHASE32020-08-102030-062029-03
NCT04451772A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease StateCOMPLETEDPHASE22020-07-272024-01-032024-01-03
NCT04403763Phase 1/2 Study of AGN-241622 in Healthy Participants and Participants With PresbyopiaTERMINATEDPHASE1, PHASE22020-07-272022-12-052022-12-05
NCT04451720Study of Subcutaneous Risankizumab Injection to Assess Change in Palmoplantar Pustulosis Area and Severity Index [PPPASI] in Adult Japanese Participants With Palmoplantar PustulosisCOMPLETEDPHASE32020-07-202022-11-212022-11-21
NCT04435600A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease SymptomsCOMPLETEDPHASE32020-07-142024-10-152024-02-12
NCT04430855A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease SymptomsCOMPLETEDPHASE22020-07-142022-01-252021-04-22
NCT04274907A Safety Study of Oral Venetoclax in Combination With Intravenous Pembrolizumab in Adult Participants With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) With High Programmed Cell Death Ligand-1 (PD-L1) ExpressionTERMINATEDPHASE12020-06-302021-02-022021-02-02
NCT04382885Cariprazine Pediatric ASD PK StudyCOMPLETEDPHASE12020-06-262021-12-102021-12-10
NCT04437433A Study Evaluating Oral Atogepant for the Prevention of Migraine in Japanese Participants With Chronic or Episodic MigraineCOMPLETEDPHASE32020-06-182024-06-112024-06-11
NCT04285580A Phase 3b Study Evaluating the 24-Hour Intraocular Pressure Lowering Effect of Bimatoprost SR in Patients With Open-Angle Glaucoma or Ocular HypertensionCOMPLETEDPHASE32020-06-112022-05-142022-05-14
NCT04379050Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's DiseaseACTIVE_NOT_RECRUITINGPHASE32020-06-082026-042026-04
NCT04375397Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary InjuryCOMPLETEDPHASE22020-06-062021-06-082021-05-10
NCT04417465First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic TumorsCOMPLETEDPHASE12020-06-032025-08-212025-08-21
NCT04254783A Study to Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's DiseaseCOMPLETEDPHASE12020-05-272022-10-142022-10-14
NCT04274933A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor TherapyTERMINATEDPHASE12020-05-212020-10-082020-10-08
NCT04178902A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory (R/R) Multiple MyelomaTERMINATEDPHASE12020-05-192021-04-162021-04-16
NCT04274894A Study of the Effect of Topical Testosterone Replacement Therapy on Blood Pressure in Adult Male Participants With HypogonadismCOMPLETEDPHASE42020-05-122022-01-072021-12-07
NCT04315311Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic CancerWITHDRAWNPHASE42020-05-062021-09-222021-09-22
NCT04272203A Study to Determine Safety, Tolerability, Pharmacokinetics, and Recommended Phase 2 Dose (RP2D) of Intravenous ABBV-184 in Adult Participants With Previously Treated CancersTERMINATEDPHASE12020-05-052022-06-272022-06-27
NCT04102020A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional ChemotherapyACTIVE_NOT_RECRUITINGPHASE32020-03-262026-062022-09-29
NCT05217472An Efficacy and Safety Study of Injectable Ravagalimab to Assess Change in EULAR Sjogren's Syndrome Disease Activity Index (ESSDAI) in Adult Participants With Moderately to Severely Active Primary Sjogren's Syndrome (pSS)WITHDRAWNPHASE22020-03-062022-05-152022-04-15
NCT04030962A Study of the Drugs AGN-242428 and AGN-231868 in Participants With Dry Eye DiseaseCOMPLETEDPHASE1, PHASE22020-03-042022-03-182022-03-18
NCT04127695A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's DiseaseWITHDRAWNPHASE12020-03-032020-06-162020-06-16
NCT04161885A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)TERMINATEDPHASE32020-02-262025-09-232025-09-23
NCT03859869A Study of Creon (Pancrelipase) in Resected and Non-resected Pancreatic Cancer Participants With Exocrine Pancreatic Insufficiency (EPI)TERMINATEDPHASE42020-02-252022-03-232022-03-23
NCT04262791A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)TERMINATEDPHASE12020-02-172022-01-312022-01-31
NCT04189614An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE12020-02-132025-122025-12
NCT04161898A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK)ACTIVE_NOT_RECRUITINGPHASE32020-02-042027-082027-08
NCT04223804A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of ABBV-181 (Budigalimab) in Adult Participants With Human Immunodeficiency Virus (HIV)-1COMPLETEDPHASE12020-01-302023-02-272023-02-27
NCT04244175A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset SeizuresCOMPLETEDPHASE22020-01-272024-05-212024-05-21
NCT04196283A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCOMPLETEDPHASE12020-01-222022-10-272022-10-27
NCT03818542A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell CarcinomaTERMINATEDPHASE12020-01-222020-09-232020-09-23
NCT04195698Open-Label Extension Study of Upadacitinib in Adult Participants With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32020-01-152023-09-112023-09-11
NCT03873493A Study Evaluating the Efficacy of Venetoclax Plus Ibrutinib in Participants With T-cell Prolymphocytic LeukemiaCOMPLETEDPHASE22020-01-142021-11-042021-11-04
NCT04223193Flexible-Dose Trial in Early Parkinson's Disease (PD)COMPLETEDPHASE32020-01-062024-10-012024-10-01
NCT04209855A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) ExpressionCOMPLETEDPHASE32019-12-312024-10-292023-03-06
NCT04201093Fixed-Dose Trial in Early Parkinson's Disease (PD)COMPLETEDPHASE32019-12-132024-06-282024-06-28
NCT03969888A Phase 2 Study of ABBV-3067 Alone and in Combination With ABBV-2222COMPLETEDPHASE22019-12-112022-06-092022-06-09
NCT04169373A Study to Evaluate Efficacy and Safety of Upadacitinib in Adults With Axial SpondyloarthritisCOMPLETEDPHASE32019-11-262025-02-212021-09-02
NCT04166058Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-CCOMPLETEDPHASE32019-11-192025-06-052025-06-05
NCT04102007A Study of the Safety and Efficacy of Risankizumab in Adult Participants With Plaque Psoriasis Who Have Had a Suboptimal Response to Secukinumab or IxekizumabCOMPLETEDPHASE32019-11-122022-11-072022-01-17
NCT04041050A Study Evaluating Safety and Tolerability, and Pharmacokinetics of Navitoclax Monotherapy and in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmACTIVE_NOT_RECRUITINGPHASE12019-11-082026-12-312026-12-31
NCT04086264IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Participants With CD123-Positive Acute Myeloid LeukemiaACTIVE_NOT_RECRUITINGPHASE1, PHASE22019-11-062027-022027-02
NCT03924947A Study to Compare US Marketed Creon Manufactured With a Modernized Process at an Alternate Manufacturing Site and Manufactured With the Approved Manufacturing Process at an Alternate Active Pharmaceutical Ingredient Site, in Participants With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisCOMPLETEDPHASE42019-10-232022-07-112022-07-11
NCT04026113Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)COMPLETEDPHASE32019-10-012024-05-292024-05-20
NCT03844048An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical TrialACTIVE_NOT_RECRUITINGPHASE32019-09-062026-022026-02
NCT04073303BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle ProminenceCOMPLETEDPHASE32019-08-292022-11-102022-11-10
NCT03941964A Study of the Effectiveness of Venetoclax in Combination With Azacitidine or Decitabine in an Outpatient Setting in Patients With Acute Myeloid Leukemia (AML) Ineligible for Intensive ChemotherapyCOMPLETEDPHASE32019-08-152022-03-142022-03-14
NCT03951077Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary SyndromeCOMPLETEDPHASE22019-08-122021-02-102021-02-10
NCT03557619A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological MalignanciesRECRUITINGPHASE12019-07-302026-03-212026-03-21
NCT03978520A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE22019-07-252022-07-142022-01-19
NCT05268068A Study of Intravenously (IV) Infused or Subcutaneously (SC) Injected Risankizumab in Healthy Adult Participants in ChinaCOMPLETEDPHASE12019-06-272020-04-262020-04-26
NCT03725007A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic ArthritisACTIVE_NOT_RECRUITINGPHASE12019-06-242027-052027-05
NCT03922607A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-157 in Healthy Volunteers and in Participants With Chronic Plaque PsoriasisCOMPLETEDPHASE12019-06-112021-04-132021-04-13
NCT03875508A Study to Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32019-06-042020-08-252020-04-24
NCT03926169A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCOMPLETEDPHASE22019-06-032021-08-022021-02-02
NCT03999801Long-term Follow-Up Study of RGX-314 and Fellow Eye SubstudyENROLLING_BY_INVITATIONPHASE22019-05-312028-122028-12
NCT03924323A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety DisorderCOMPLETEDPHASE42019-05-302021-09-202021-09-20
NCT03893955A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITINGPHASE12019-05-212026-032026-03
NCT03823378A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With UpadacitinibTERMINATEDPHASE22019-05-132020-09-092020-09-09
NCT03875482A Study to Assess Safety and Efficacy of Risankizumab Using a New Formulation in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32019-05-132020-07-152020-02-20
NCT03781167A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)COMPLETEDPHASE32019-04-292022-08-172022-08-17
NCT03785184A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose TherapyWITHDRAWNPHASE22019-04-292019-08-222019-08-22
NCT03886220A Study to Evaluate the Safety and Efficacy of Elagolix for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCOMPLETEDPHASE42019-04-122021-04-282021-03-31
NCT05283681A Study to Evaluate the Bioavailability of Risankizumab in Pre-filled Syringe or Auto-injector in Healthy Adult ParticipantsCOMPLETEDPHASE12019-04-022019-11-112019-11-11
NCT03891446Long-term Safety and Efficacy Extension Trial of Bimatoprost SRACTIVE_NOT_RECRUITINGPHASE32019-03-272026-082026-07
NCT03823391A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)COMPLETEDPHASE22019-03-272020-08-262020-04-08
NCT03695185A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior TherapyCOMPLETEDPHASE22019-03-262022-01-102021-04-05
NCT03675308A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) TherapyACTIVE_NOT_RECRUITINGPHASE32019-03-252026-09-282020-10-08
NCT03712787An Extension Study of ABBV-8E12 in Early Alzheimer's Disease (AD)TERMINATEDPHASE22019-03-222021-09-302021-09-30
NCT03797261A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic MalignanciesTERMINATEDPHASE12019-03-182019-12-302019-12-30
NCT05486195A Single Ascending Oral Dose Study of SDI-118 in Healthy Male Subjects Including an Assessment of Receptor Occupancy and Food EffectCOMPLETEDPHASE12019-03-142020-03-112019-07-29
NCT03671148A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)ACTIVE_NOT_RECRUITINGPHASE32019-03-072026-062020-06-22
NCT03779841Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)COMPLETEDPHASE22019-03-012023-03-062022-03-24
NCT03850782Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular HypertensionCOMPLETEDPHASE32019-02-282025-08-082025-08-08
NCT03737812A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple SclerosisCOMPLETEDPHASE22019-02-272021-08-302021-01-15
NCT03821935Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITINGPHASE12019-02-212027-062027-06
NCT03738397A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32019-02-212020-12-092020-08-27
NCT03725202A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell ArteritisCOMPLETEDPHASE32019-02-062025-02-242024-02-06
NCT03646604A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic DermatitisCOMPLETEDPHASE12019-01-312024-08-292024-08-29
NCT03706040A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE22018-12-272021-04-262020-10-28
NCT03737851A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple SclerosisCOMPLETEDPHASE22018-12-112021-09-092021-08-09
NCT03653026A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE32018-12-062021-01-142021-01-14
NCT03739203The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneCOMPLETEDPHASE32018-11-102021-09-062021-09-06
NCT03738215Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants AloneCOMPLETEDPHASE32018-11-092021-09-302021-09-30
NCT03661138A Study to Evaluate Safety of Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE32018-10-272022-08-192022-08-19
NCT03695237A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)COMPLETEDPHASE32018-10-242023-11-292021-05-06
NCT03639194A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung CancerCOMPLETEDPHASE12018-10-242024-01-252024-01-25
NCT03539744A Study Designed to Evaluate the Safety and Efficacy of Venetoclax Plus Dexamethasone (VenDex) Compared With Pomalidomide Plus Dexamethasone (PomDex) in Participants With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma.ACTIVE_NOT_RECRUITINGPHASE32018-10-222027-112026-08
NCT03625505A Study to Assess Safety and Efficacy of Venetoclax in Combination With Gilteritinib in Participants With Relapsed/Refractory Acute Myeloid LeukemiaCOMPLETEDPHASE12018-10-182021-08-312021-08-31
NCT03567616A Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Participants With Relapsed or Refractory Multiple MyelomaTERMINATEDPHASE22018-10-182020-06-182020-06-18
NCT03539536Study of Telisotuzumab Vedotin (ABBV-399) in Participants With Previously Treated c-Met+ Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE22018-10-102026-082025-10
NCT03682705A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisCOMPLETEDPHASE22018-10-082020-03-262020-03-26
NCT03543358A Long-Term Study of Rovalpituzumab TesirineCOMPLETEDPHASE22018-09-102019-11-262019-11-26
NCT03398135A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative ColitisACTIVE_NOT_RECRUITINGPHASE32018-08-282029-022029-02
NCT03569293Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)ACTIVE_NOT_RECRUITINGPHASE32018-08-132025-09-092021-01-06
NCT03406156A Study in Previously Untreated Chronic Lymphocytic Leukemia (CLL) Subjects, Excluding Those With the 17p Deletion, to Evaluate Debulking Regimens Prior to Initiating Venetoclax Combination TherapyCOMPLETEDPHASE32018-08-102023-07-122021-10-12
NCT03568318A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic DermatitisENROLLING_BY_INVITATIONPHASE32018-08-092030-10-232021-02-16
NCT03219437A Study Comparing the Safety and Efficacy of Risankizumab to Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32018-07-302021-11-262021-11-26
NCT03593213Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With SchizophreniaTERMINATEDPHASE32018-07-302021-02-112021-02-11
NCT03419403UNITE Study: Understanding New Interventions With GBM ThErapyTERMINATEDPHASE32018-07-302020-03-032019-09-05
NCT03607422A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)ACTIVE_NOT_RECRUITINGPHASE32018-07-272025-11-042021-03-11
NCT03484520A Study of Venetoclax and Dinaciclib (MK7965) in Patients With Relapsed/Refractory Acute Myeloid LeukemiaTERMINATEDPHASE12018-07-232022-12-012022-12-01
NCT03518047Risankizumab Therapy Versus Placebo for Subjects With Psoriasis in the Russian FederationCOMPLETEDPHASE32018-07-192020-02-112020-02-11
NCT03595059A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid TumorsACTIVE_NOT_RECRUITINGPHASE12018-07-132025-062025-06
NCT03573297A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed FeaturesCOMPLETEDPHASE32018-06-152022-09-052022-09-05
NCT03219216A Study to Evaluate the Efficacy and Safety of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults in Brazil With Chronic Hepatitis C Virus (HCV) Genotype 1 - 6 InfectionCOMPLETEDPHASE32018-06-062019-03-112019-03-11
NCT03441555A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid LeukemiaCOMPLETEDPHASE12018-05-302021-01-252021-01-25
NCT03478787Risankizumab Versus Secukinumab for Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32018-05-082020-07-082020-07-08
NCT03518034A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal MenCOMPLETEDPHASE42018-05-032023-01-192023-01-19
NCT03374917A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient EnvironmentCOMPLETEDPHASE12018-04-182019-03-042019-03-04
NCT03413319Extension Study of ABBV-8E12 in Patients With Progressive Supranuclear Palsy (PSP) Who Completed Study C2N-8E12-WW-104COMPLETEDPHASE12018-04-172019-11-202019-11-20
NCT03105102A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE32018-04-092026-052026-05
NCT03314181A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple MyelomaACTIVE_NOT_RECRUITINGPHASE22018-04-022031-052031-05
NCT03345823A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433ACTIVE_NOT_RECRUITINGPHASE32018-03-212027-092027-09
NCT03368859A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and BevacizumabTERMINATEDPHASE22018-03-202019-12-182019-12-18
NCT03360006A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Participants With Relapsed/Refractory Acute Myeloid Leukemia (AML) CancerTERMINATEDPHASE12018-03-162020-12-192020-12-19
NCT03334487Study Evaluating the Safety of Rovalpituzumab Tesirine for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Small Cell Lung CancerWITHDRAWNPHASE32018-03-152018-12-202018-12-20
NCT03398148A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE2, PHASE32018-03-072023-05-112022-11-09
NCT03391765An Extension Study of ABBV-8E12 in Progressive Supranuclear Palsy (PSP)TERMINATEDPHASE22018-01-242019-12-132019-12-13
NCT03316794A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)TERMINATEDPHASE12018-01-042018-10-052018-10-05
NCT02955212A Study With Upadacitinib (ABT-494) in Subjects From China and Selected Countries With Moderately to Severely Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs)COMPLETEDPHASE32018-01-032020-09-032019-08-14
NCT03386513Study of IMGN632 in Patients With Untreated BPDCN and Relapsed/Refractory BPDCNACTIVE_NOT_RECRUITINGPHASE1, PHASE22018-01-022026-12-302023-09-06
NCT03343067A Study to Evaluate Safety and Efficacy of Elagolix in Participants With Endometriosis With Associated Moderate to Severe PainTERMINATEDPHASE32017-12-272018-10-232018-10-23
NCT03104413A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease Who Failed Prior Biologic TreatmentCOMPLETEDPHASE32017-12-182021-05-192020-11-30
NCT03345849A Study of the Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic TherapiesCOMPLETEDPHASE32017-12-072022-01-132021-10-15
NCT03345836A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic TherapyCOMPLETEDPHASE32017-11-292021-08-112021-08-11
NCT03181126A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic LymphomaCOMPLETEDPHASE12017-11-272020-11-142020-11-11
NCT03339128Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in ChildrenRECRUITINGPHASE22017-11-152026-122026-12
NCT03236857A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesCOMPLETEDPHASE12017-11-082023-04-192023-04-19
NCT03311477A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid TumorsCOMPLETEDPHASE12017-11-062019-03-042019-03-04
NCT03222609A Study Evaluating Tolerability and Efficacy of Navitoclax Alone or in Combination With Ruxolitinib in Participants With MyelofibrosisCOMPLETEDPHASE22017-10-312025-01-292022-03-28
NCT03311464A Study Assessing the Efficacy and Safety of Adalimumab in Active Ulcer(s) of Pyoderma Gangrenosum in Participants in JapanCOMPLETEDPHASE32017-10-272020-04-212019-08-20
NCT03178487A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing SpondylitisCOMPLETEDPHASE22017-10-242022-02-172019-01-21
NCT05305222A Study in Healthy Japanese and Caucasian Subjects to Assess the Pharmacokinetics, Safety and Tolerability of RisankizumabCOMPLETEDPHASE12017-10-232018-06-152018-06-15
NCT02966756A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRECRUITINGPHASE22017-10-122029-052029-05
NCT03234712A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)COMPLETEDPHASE12017-10-102021-04-142021-04-14
NCT03222583A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced, Non-Cirrhotic Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With or Without Human Immunodeficiency Virus Co-InfectionCOMPLETEDPHASE32017-10-042019-02-152018-10-18
NCT03235349Efficacy and Safety of Glecaprevir/Pibrentasvir (ABT-493/ABT-530) in Treatment-Naive and Treatment-Experienced Asian Adults With Chronic Hepatitis C Virus Genotype (GT) 1 to GT6 Infection With Compensated Cirrhosis and With or Without Human Immunodeficiency Virus Co-InfectionCOMPLETEDPHASE32017-09-292019-02-252018-11-15
NCT03271489Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCOMPLETEDPHASE32017-09-132024-06-282024-06-28
NCT03253185A Study of SC-007 in Subjects With Advanced CancerTERMINATEDPHASE12017-09-132018-04-022018-03-20
NCT05283694A Study to Evaluate the Bioavailability of Risankizumab Following Subcutaneous Dosing in Healthy Male ParticipantsCOMPLETEDPHASE12017-09-112018-06-122018-06-12
NCT02951117A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer TreatmentWITHDRAWNPHASE12017-08-312021-04-282020-07-28
NCT03255382A Study to Assess the Efficacy of Risankizumab Compared to FUMADERM® in Subjects With Moderate to Severe Plaque Psoriasis Who Are Naïve to and Candidates for Systemic TherapyCOMPLETEDPHASE32017-08-222018-07-062018-07-06
NCT03212521Efficacy and Safety of 8-weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve Adults With HCV Genotype 1-6 and Aspartate Aminotransferase to Platelet Ratio Index (APRI) ≤1COMPLETEDPHASE32017-08-072018-08-132018-08-13
NCT03213457A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated PainCOMPLETEDPHASE32017-07-072023-12-062020-03-27
NCT03145909A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR)TERMINATEDPHASE12017-07-032018-11-272018-11-27
NCT03138408SC-004 Alone or With ABBV-181 in Subjects With Epithelial Ovarian, Fallopian Tube, Primary Peritoneal and Endometrial CancersTERMINATEDPHASE12017-06-142019-05-022019-05-02
NCT03069352A Study of Venetoclax in Combination With Low Dose Cytarabine Versus Low Dose Cytarabine Alone in Treatment Naive Patients With Acute Myeloid Leukemia Who Are Ineligible for Intensive ChemotherapyCOMPLETEDPHASE32017-05-232025-08-212019-02-15
NCT03033498A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous Infusions of ABBV-951 in Subjects With Parkinson's DiseaseCOMPLETEDPHASE12017-05-172019-06-082019-06-08
NCT03148756Efficacy and Safety of Dalbavancin Compared to Standard of Care Antibiotic Therapy for the Completion of Treatment of Patients With Complicated Bacteremia or Infective EndocarditisTERMINATEDPHASE22017-05-122017-08-042017-08-04
NCT03105128A Study of the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE32017-05-102021-04-142020-11-09
NCT03086343A Phase 3 Study to Compare Upadacitinib to Abatacept in Subjects With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease- Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response or Intolerance to Biologic DMARDsCOMPLETEDPHASE32017-05-092023-06-062019-06-13
NCT03145948A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ABBV-553 in Healthy Volunteers and in Subjects With Psoriasis and Efficacy of ABBV-553 in Subjects With PsoriasisTERMINATEDPHASE12017-05-092017-08-162017-08-16
NCT03104374A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic DrugCOMPLETEDPHASE32017-05-012024-09-302019-07-23
NCT03086239A Study on the Safety and Tolerability of Rovalpituzumab Tesirine in Japanese Patients With Advanced, Recurrent Small Cell Lung CancerCOMPLETEDPHASE12017-04-282018-08-202018-01-30
NCT03089944A Study of Glecaprevir (GLE)/Pibrentasvir (PIB) in Treatment-Naive Adults With Chronic Hepatitis C Virus (HCV) Genotype 1-6 Infection and Compensated CirrhosisCOMPLETEDPHASE32017-04-282019-11-082019-07-31
NCT03104400A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)COMPLETEDPHASE32017-04-272024-09-092019-09-26
NCT03061812Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)COMPLETEDPHASE32017-04-112020-02-122020-02-12
NCT02814916Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSACOMPLETEDPHASE32017-03-302024-01-012024-01-01
NCT03026166A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung CancerTERMINATEDPHASE1, PHASE22017-03-302019-07-032019-07-03
NCT03069365A Study to Evaluate the Efficacy and Safety of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection and Renal ImpairmentCOMPLETEDPHASE32017-03-282018-06-052018-02-20
NCT03071757A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid TumorsCOMPLETEDPHASE12017-03-212022-04-132022-04-13
NCT03067129A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE2, PHASE32017-03-202022-09-122020-05-21
NCT03082209A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic MalignanciesCOMPLETEDPHASE12017-03-202022-01-212022-01-21
NCT03035279A Study of SC-006 and in Combination With ABBV-181 in Subjects With Advanced Colorectal CancerTERMINATEDPHASE12017-03-082019-03-282019-03-28
NCT02966782A Study Evaluating Venetoclax Alone and in Combination With Azacitidine in Participants With Relapsed/Refractory Myelodysplastic Syndromes (MDS)COMPLETEDPHASE12017-03-072023-04-052023-04-05
NCT03047395A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )COMPLETEDPHASE32017-02-272023-11-292023-11-29
NCT02988960A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITINGPHASE12017-02-222026-032026-03
NCT02799381A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)COMPLETEDPHASE32017-02-092019-09-192019-09-19
NCT03033511A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)TERMINATEDPHASE32017-02-072019-11-202019-11-20
NCT02993523A Study of Venetoclax in Combination With Azacitidine Versus Azacitidine in Treatment NaĂŻve Participants With Acute Myeloid Leukemia Who Are Ineligible for Standard Induction TherapyACTIVE_NOT_RECRUITINGPHASE32017-02-022026-01-232021-12-01
NCT03006068A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Participants With Ulcerative Colitis (UC)ACTIVE_NOT_RECRUITINGPHASE32017-01-312027-072027-07
NCT02880956A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Participants With Early Alzheimer's DiseaseCOMPLETEDPHASE22017-01-262021-07-282021-03-30
NCT03022045A Study to Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic PsoriasisCOMPLETEDPHASE32017-01-262020-11-192017-09-17
NCT02966795A Study of of Glecaprevir/Pibrentasvir in Adults With Chronic Hepatitis C Virus (HCV) Genotype 5 or 6 InfectionCOMPLETEDPHASE32017-01-252018-08-292018-06-06
NCT02899052Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)ACTIVE_NOT_RECRUITINGPHASE22017-01-192027-062027-06
NCT02942290A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-NaĂŻve Higher-Risk Myelodysplastic Syndromes (MDS)ACTIVE_NOT_RECRUITINGPHASE12017-01-122027-012027-01
NCT02944396Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE12016-12-232019-10-022019-10-02
NCT02986373A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171)COMPLETEDPHASE22016-12-152018-07-302018-07-08
NCT03000257A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid TumorsCOMPLETEDPHASE12016-12-142022-03-292022-03-29
NCT02980731A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).COMPLETEDPHASE32016-12-132021-12-292021-12-29
NCT02985879A Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of ABBV-8E12 in Subjects With Progressive Supranuclear Palsy (PSP)TERMINATEDPHASE22016-12-122019-11-202019-11-20
NCT03000075BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE22016-12-022018-06-202017-09-21
NCT02939989Efficacy and Safety of Glecaprevir (ABT-493)/Pibrentasvir (ABT 530) (GLE/PIB) in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical StudyCOMPLETEDPHASE32016-11-212021-07-302021-05-07
NCT02955251A Study of ABBV-428, an Immunotherapy, in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12016-11-182019-10-292019-10-29
NCT02968173A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of BelarusCOMPLETEDPHASE32016-11-092017-07-132017-07-13
NCT02925117A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic DermatitisCOMPLETEDPHASE22016-10-252019-01-312017-08-10
NCT02601885A Multiple Dose Study of ABT-555 in Subjects With Relapsing Forms of Multiple SclerosisCOMPLETEDPHASE12016-10-182018-04-202018-04-20
NCT02819999A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung CancerTERMINATEDPHASE12016-102019-05-312019-05-31
NCT02819635A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)COMPLETEDPHASE2, PHASE32016-09-262021-12-132021-12-13
NCT02709889Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid TumorsTERMINATEDPHASE1, PHASE22016-09-232019-08-272019-08-27
NCT02772601This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic ArthritisCOMPLETEDPHASE12016-09-152017-09-222017-06-15
NCT02925494An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsCOMPLETEDPHASE32016-09-142019-03-222018-05-07
NCT02897115A Study Treating Participants With Early Axial Spondyloarthritis (axSpA) Taking an Intense Treatment Approach Versus Routine TreatmentTERMINATEDPHASE42016-09-122017-12-212017-12-21
NCT02904902Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis SuppurativaCOMPLETEDPHASE32016-09-062019-05-302017-09-01
NCT02806362Study of Ombitasvir/Paritaprevir/Ritonavir in Japanese Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection With End Stage Renal Disease (ESRD) on Hemodialysis (HD)WITHDRAWNPHASE32016-092018-082018-06
NCT02814175A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)COMPLETEDPHASE42016-08-052020-03-192019-09-23
NCT02808975Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-SurgicallyCOMPLETEDPHASE42016-07-182019-10-162019-05-16
NCT02755597A Study Evaluating Venetoclax (ABT-199) in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard TherapyCOMPLETEDPHASE32016-07-112022-08-152021-03-15
NCT02640833A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K InhibitorWITHDRAWNPHASE12016-072021-022020-01
NCT02756611A Study to Evaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)COMPLETEDPHASE32016-06-222022-03-112019-04-10
NCT02782663A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's DiseaseCOMPLETEDPHASE22016-05-182025-07-182025-07-18
NCT02738138A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)COMPLETEDPHASE32016-05-172017-06-072017-03-15
NCT02692703A Study to Evaluate the Safety and Efficacy of ABT-493/ABT-530 in Adult Post-Liver or Post-Renal Transplant Recipients With Chronic Hepatitis C Virus (MAGELLAN-2)COMPLETEDPHASE32016-04-222017-06-292017-04-13
NCT02723084A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE32016-04-082017-03-242017-01-19
NCT02688790Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial InfectionTERMINATEDPHASE12016-04-012019-04-032019-04-03
NCT02719171BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic ArthritisCOMPLETEDPHASE22016-042017-082017-05
NCT02706951A Study Comparing Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to MTX (SELECT-MONOTHERAPY)COMPLETEDPHASE32016-03-232022-08-102017-10-02
NCT02720523A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis (RA) Who Are on a Stable Dose of Conventional Synthetic Disease-Modifying Anti-Rheumatic Drugs (csDMARDs) and Have an Inadequate Response to csDMARDsCOMPLETEDPHASE2, PHASE32016-03-222022-06-072017-08-03
NCT02706847A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDsCOMPLETEDPHASE32016-03-152022-02-082017-04-03
NCT02684357BI 655066 Versus Placebo & Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE32016-032017-092016-12
NCT02694523BI 655066/ABBV-066 (Risankizumab) Compared to Active Comparator (Adalimumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE32016-032017-082017-08
NCT02672852BI 655066 / ABBV-066 (Risankizumab) in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatmentCOMPLETEDPHASE32016-02-292018-07-262017-08-02
NCT02706873A Study to Compare Upadacitinib (ABT-494) Monotherapy to Methotrexate (MTX) Monotherapy in Adults With Rheumatoid Arthritis (RA) Who Have Not Previously Taken MethotrexateCOMPLETEDPHASE32016-02-232022-11-102018-03-15
NCT02707952A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Japanese Adults With Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE32016-02-222017-02-092016-11-14
NCT02691494Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women (Replicate Study)COMPLETEDPHASE32016-02-032019-01-232018-02-14
NCT02684370BI 655066 (Risankizumab) Compared to Placebo and Active Comparator (Ustekinumab) in Patients With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE32016-022017-092016-12
NCT02674568Study of Rovalpituzumab Tesirine (SC16LD6.5) for Third-Line and Later Treatment of Subjects With Relapsed or Refractory Delta-Like Protein 3-Expressing Small Cell Lung CancerCOMPLETEDPHASE22016-01-252018-10-192018-10-19
NCT02654054Efficacy and Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal WomenCOMPLETEDPHASE32015-12-222018-12-122018-01-18
NCT02675426A Study Comparing Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on a Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) Who Have an Inadequate Response to csDMARDs AloneCOMPLETEDPHASE32015-12-172022-03-102017-04-21
NCT02556736RST-001 Phase I/II Trial for Advanced Retinitis PigmentosaCOMPLETEDPHASE1, PHASE22015-12-142024-10-212020-06-01
NCT02642432A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated CirrhosisCOMPLETEDPHASE32015-12-072017-02-102016-10-27
NCT02629159A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to MethotrexateACTIVE_NOT_RECRUITINGPHASE32015-12-012027-09-302017-10-27
NCT02640157A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 InfectionCOMPLETEDPHASE32015-122017-022016-10
NCT02573740Safety, Tolerability and the Effects on Cerebrospinal Fluid Spectrin Breakdown Product-145 Levels of ABT-957 in Subjects With Mild Alzheimer's Disease and Mild Cognitive ImpairmentTERMINATEDPHASE12015-122016-062016-06
NCT02651194A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 InfectionCOMPLETEDPHASE32015-122017-012016-10
NCT02632175Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative ColitisCOMPLETEDPHASE32015-11-262025-04-082025-04-08
NCT02582632A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-NaĂŻve Hepatitis C Virus Genotype 1b-Infected AdultsCOMPLETEDPHASE32015-11-242016-12-012016-08-24
NCT02636595The Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 4, 5, or 6 Infection (ENDURANCE-4)COMPLETEDPHASE32015-112017-012016-10
NCT02640482A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 InfectionCOMPLETEDPHASE32015-112017-022016-09
NCT02598570Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory LymphomaCOMPLETEDPHASE12015-112017-022016-12
NCT02486406A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric SubjectsCOMPLETEDPHASE2, PHASE32015-10-282020-11-192020-11-19
NCT02609659Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE32015-10-282016-12-282016-10-07
NCT02549092A Study to Examine the Effect of Levodopa-Carbidopa Intestinal Gel (LCIG) Therapy Relative to That of Optimized Medical Treatment (OMT) on Non-motor Symptoms (NMS) Associated With Advanced Parkinson's Disease (PD)COMPLETEDPHASE32015-10-262022-11-182020-05-14
NCT02604017A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 InfectionCOMPLETEDPHASE32015-102017-012017-01
NCT02606630[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple SclerosisTERMINATEDPHASE12015-102015-122015-12
NCT02429895A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197TERMINATEDPHASE22015-102016-052016-05
NCT02487199Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney DiseaseCOMPLETEDPHASE32015-09-302016-12-052016-12-05
NCT02533375Study to Investigate Efficacy and Safety of Adalimumab in Japanese Subjects With Generalized Pustular Psoriasis (GPP)COMPLETEDPHASE32015-09-282017-07-202016-09-15
NCT02565758ABBV-085, an Antibody Drug Conjugate, in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12015-09-182019-03-252019-03-25
NCT02513459A Long Term Extension Trial of BI 655066/ABBV-066 (Risankizumab), in Patients With Moderately to Severely Active Crohn's DiseaseCOMPLETEDPHASE22015-09-162019-06-192019-06-19
NCT02534870Pharmacokinetics and Safety of the Co-administration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Healthy Chinese SubjectsCOMPLETEDPHASE12015-092015-092015-09
NCT02507687Comparison of Bimatoprost Sustained Release (SR) to Selective Laser Trabeculoplasty (SLT) in Adults With Open-Angle Glaucoma or Ocular HypertensionCOMPLETEDPHASE32015-08-272023-05-312021-11-24
NCT02590263Study Evaluating ABT-414 in Japanese Subjects With Malignant GliomaCOMPLETEDPHASE1, PHASE22015-08-242020-08-272020-08-27
NCT02499783Study to Evaluate the Safety and Efficacy of Adalimumab in Chinese Subjects With Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE32015-08-172017-12-152017-05-19
NCT02596217Safety, Tolerability and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Healthy Asian and Caucasian Male VolunteersCOMPLETEDPHASE12015-082017-062017-06
NCT02517528ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment NaĂŻve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated CirrhosisCOMPLETEDPHASE32015-07-202017-03-162016-09-29
NCT02470585Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerTERMINATEDPHASE32015-07-142023-10-052019-05-03
NCT02504099A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/r With or Without Dasabuvir and With or Without Ribavirin in Chronic Hepatitis C Virus Genotype 1 or 4 Infected Adults With Successfully Treated Early Stage Hepatocellular CarcinomaTERMINATEDPHASE32015-072016-122016-09
NCT02517515ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Treatment-NaĂŻve and Treatment-Experienced, Non-Cirrhotic Asian Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE32015-072017-062016-10
NCT02483104Veliparib in Combination With Carboplatin And Weekly Paclitaxel in Japanese Subjects With Ovarian CancerCOMPLETEDPHASE12015-072016-072016-03
NCT02531178A Study to Assess the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABBV-257 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE12015-072016-022016-02
NCT02443298Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent AsthmaCOMPLETEDPHASE22015-06-232018-02-022017-10-13
NCT02441283A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530COMPLETEDPHASE2, PHASE32015-06-222019-10-152019-10-15
NCT02493855Ombitasvir/ABT-450/Ritonavir and Dasabuvir Therapy With Low Dose Ribavirin (RBV), Full Dose RBV or RBV Add-On in Treatment Naive Genotype 1a Hepatitis C Virus Infected AdultsCOMPLETEDPHASE22015-062016-122016-04
NCT02476617Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected AdultsCOMPLETEDPHASE32015-062016-122016-08
NCT02442284A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin in US Veterans With Genotype 1 Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE32015-05-132016-10-312016-08-22
NCT02462525Dose-Escalation Study of ABBV-838, an Antibody Drug Conjugate, in Subjects With Relapsed and Refractory Multiple MyelomaTERMINATEDPHASE12015-05-062017-12-062017-12-06
NCT02412371A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Adults With Stage III Non-Small Cell Lung Cancer (NSCLC)TERMINATEDPHASE1, PHASE22015-04-302019-08-052019-08-05
NCT02349451A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX)COMPLETEDPHASE22015-04-282016-07-042016-07-04
NCT02442271A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs in Adults With Hepatitis C Virus Infection, Who Are Either Treatment-naive or Treatment-experienced in BrazilCOMPLETEDPHASE32015-04-272016-09-262016-07-04
NCT02391480A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With CancerCOMPLETEDPHASE12015-04-142019-07-052019-07-05
NCT02118714Atrasentan Spermatogenesis and Testicular FunctionCOMPLETEDPHASE22015-04-062018-07-162018-04-18
NCT02446717A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing TherapyCOMPLETEDPHASE2, PHASE32015-042017-012016-12
NCT02433340Phase 2, Multicenter, Open-Label Extension Study With ABT-122 in Rheumatoid Arthritis Subjects Who Have Completed the Preceding M12-963 StudyCOMPLETEDPHASE22015-042016-052016-05
NCT02365649A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF TherapyCOMPLETEDPHASE22015-03-172017-08-032016-11-25
NCT02384538A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand OsteoarthritisCOMPLETEDPHASE22015-032016-072016-07
NCT02399345Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected AdultsCOMPLETEDPHASE32015-032015-112015-11
NCT02442258Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal FunctionCOMPLETEDPHASE12015-032015-122015-12
NCT02343406Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade GliomasCOMPLETEDPHASE22015-02-172019-06-242019-06-24
NCT02356562A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE22015-02-032017-07-072016-10-28
NCT02365662A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorTERMINATEDPHASE12015-01-092018-03-152018-03-15
NCT02198651A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) SubjectsCOMPLETEDPHASE42015-01-052018-08-082018-05-03
NCT02573324A Study of ABT-414 in Participants With Newly Diagnosed Glioblastoma (GBM) With Epidermal Growth Factor Receptor (EGFR) AmplificationCOMPLETEDPHASE32015-01-042022-04-042022-04-04
NCT02287233A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-NaĂŻve Participants With Acute Myelogenous LeukemiaCOMPLETEDPHASE1, PHASE22014-12-312021-08-102021-08-10
NCT02292719A Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir With Sofosbuvir With or Without Ribavirin in Adults With Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE22014-12-192017-07-142017-07-14
NCT02305758Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal CancerCOMPLETEDPHASE22014-12-022017-09-222017-09-22
NCT02219477A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated CirrhosisCOMPLETEDPHASE32014-11-242017-03-032016-06-13
NCT02203851Extension Trial Assessing the Safety and Efficacy of BI 655066/ABBV-066/Risankizumab in Patients With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE22014-11-202018-09-042018-09-04
NCT02247401Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in EgyptCOMPLETEDPHASE32014-11-042016-08-012016-08-01
NCT02219490A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE32014-10-302021-05-132021-05-13
NCT02265237A Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Ombitasvir/ABT-450/Ritonavir Co-administered With Ribavirin (RBV) in Adults With Genotype 4 Chronic Hepatitis C Virus (HCV) Infection and Cirrhosis (AGATE-1)COMPLETEDPHASE32014-10-282017-04-072016-07-28
NCT02065557Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative ColitisCOMPLETEDPHASE32014-10-132020-02-072020-02-07
NCT02289690Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22014-10-132019-04-172019-04-17
NCT02203773Study of ABT-199 (GDC-0199) in Combination With Azacitidine or Decitabine (Chemo Combo) in Subjects With Acute Myelogenous Leukemia (AML)TERMINATEDPHASE12014-10-062022-06-162022-06-16
NCT02296905Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic FunctionCOMPLETEDPHASE12014-102015-092015-09
NCT02264990Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former SmokersCOMPLETEDPHASE32014-09-302020-02-212019-11-14
NCT02207088Ombitasvir/ABT-450/Ritonavir and Dasabuvir With or Without Ribavirin in HCV Genotype 1-Infected Adults With Chronic Kidney DiseaseCOMPLETEDPHASE32014-09-232016-12-062016-12-06
NCT02265731Study Evaluating Venetoclax in Subjects With Hematological MalignanciesCOMPLETEDPHASE1, PHASE22014-09-222021-03-122021-03-12
NCT02243293A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 InfectionCOMPLETEDPHASE2, PHASE32014-09-192017-02-232016-10-25
NCT02141282A Phase 2 Open-Label Study of the Efficacy and Safety of ABT-199 (GDC-0199) in Chronic Lymphocytic Leukemia (CLL) Subjects With Relapse or Refractory to B-Cell Receptor Signaling Pathway Inhibitor TherapyCOMPLETEDPHASE22014-09-102021-12-222021-12-22
NCT02220738Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABT-957 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsTERMINATEDPHASE12014-092016-032016-03
NCT02219503A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and CirrhosisCOMPLETEDPHASE32014-092015-092015-06
NCT02216422A Study to Evaluate Chronic Hepatitis C Virus (HCV) Infection in Cirrhotic Adults With Genotype 1b (GT1b) InfectionCOMPLETEDPHASE32014-092015-122015-12
NCT02095574A Pharmacokinetic Study to Access How the Body Absorbs and Removes ABT-199 in Adults With Non-Hodgkin's LymphomaWITHDRAWNPHASE12014-092015-012014-09
NCT02185014Open Label Study to Evaluate Long Term Efficacy, Safety and Tolerability of Repeated Dosing in Subjects With Crohn's Disease and Who Participated and Successfully Completed M14-115COMPLETEDPHASE32014-08-122017-11-032017-11-03
NCT02196701Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR StudyCOMPLETEDPHASE32014-08-052017-03-172017-03-17
NCT02243280A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-administration of ABT-493 and ABT-530 With and Without Ribavirin in Subjects With HCV Genotype 1, 4, 5, and 6 InfectionCOMPLETEDPHASE22014-082016-022016-02
NCT02141997A Study to Investigate the Safety and Efficacy of ABT-122 Given With Methotrexate in Subjects With Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateCOMPLETEDPHASE22014-072015-112015-09
NCT02210663A Phase 1 Study of Single Agent Veliparib in Japanese Subjects With Advanced Solid TumorsCOMPLETEDPHASE12014-072016-072016-01
NCT02167945A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE32014-06-122021-05-132021-05-13
NCT02087904A Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee OsteoarthritisCOMPLETEDPHASE22014-06-042016-12-132016-06-07
NCT02148718Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s DiseaseCOMPLETEDPHASE42014-062017-012016-08
NCT02143713Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated PainCOMPLETEDPHASE32014-05-272017-05-232016-06-22
NCT02065570Study to Evaluate Efficacy and Safety of Two Drug Regimens in Subjects With Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE32014-05-012020-01-302020-01-30
NCT02106546Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung CancerCOMPLETEDPHASE32014-04-102019-11-202017-01-03
NCT02163694A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast CancerCOMPLETEDPHASE32014-04-082024-01-252019-04-05
NCT02032277A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast CancerCOMPLETEDPHASE32014-04-022020-11-122016-03-18
NCT02068222A Study to Evaluate the Safety and Antiviral Effect of ABT-450/Ritonavir and ABT-530 Coadministered With and Without Ribavirin in Adults With Genotype 3 Hepatitis C (HCV) InfectionCOMPLETEDPHASE22014-042015-032015-03
NCT01969682A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199WITHDRAWNPHASE12014-042014-052014-05
NCT02065622Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative ColitisCOMPLETEDPHASE32014-03-272019-11-112019-09-05
NCT02066389A Study Investigating the Efficacy and Safety of Upadacitinib (ABT-494) Given With Methotrexate (MTX) in Adults With Rheumatoid Arthritis Who Have Had an Inadequate Response to MTX AloneCOMPLETEDPHASE22014-03-262015-07-022015-07-02
NCT02082249An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsCOMPLETEDPHASE32014-03-102019-10-312019-10-31
NCT02082197An Efficacy and Safety Study of ABT-SLV176 for the Treatment of Hypogonadal MenWITHDRAWNPHASE32014-032015-062015-06
NCT02031276Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.COMPLETEDPHASE22014-022016-112015-12
NCT02047110BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)COMPLETEDPHASE22014-01-282016-07-252015-03-05
NCT02049138An Open-label Extension Study Evaluating the Safety and Efficacy of Upadacitinib (ABT-494) in Adults With Rheumatoid ArthritisCOMPLETEDPHASE22014-01-242021-07-292021-07-29
NCT02099058A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Participants With Advanced Solid TumorsACTIVE_NOT_RECRUITINGPHASE12014-01-152026-082026-08
NCT02023112Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT- 267 (ABT-450/r/ABT-267) in Japanese Adults With Genotype 2 Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE32014-012015-092015-04
NCT02016482A Study to Evaluate the Safety and Efficacy of Adalimumab in Subjects With Chronic Plaque Psoriasis and Nail PsoriasisCOMPLETEDPHASE32014-012016-042015-10
NCT02052362Bioavailability of ABT-450 and ABT-267 With RitonavirCOMPLETEDPHASE12014-012014-022014-02
NCT01969695An Extension Study of ABT-199 in Subjects With Advanced Non-Hodgkin's LymphomaCOMPLETEDPHASE12013-12-202019-12-162019-12-16
NCT02033551A Study Evaluating Veliparib as a Single Agent or in Combination With Chemotherapy in Subjects With Solid TumorsCOMPLETEDPHASE12013-122016-092016-09
NCT02023099Study to Evaluate the Efficacy and Safety of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) in Japanese Adults With Subgenotype 1b Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE32013-122015-102014-10
NCT02015793Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE22013-122015-022015-02
NCT01969669A Study to Assess the Effect of Ketoconazole on the Metabolism of ABT-199COMPLETEDPHASE12013-122014-092014-09
NCT01995071A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)COMPLETEDPHASE22013-112015-062015-06
NCT01994837A Phase 2 Study of ABT-199 in Subjects With Acute Myelogenous Leukemia (AML)COMPLETEDPHASE22013-112014-122014-12
NCT02009631A Study to Evaluate the Effects of Veliparib on Heart Rhythms in Patients With Solid TumorsCOMPLETEDPHASE12013-112014-122014-12
NCT02052349Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy SubjectsCOMPLETEDPHASE12013-112013-122013-12
NCT01960855A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic TherapyCOMPLETEDPHASE22013-102015-072015-07
NCT01960842A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian MedicationsCOMPLETEDPHASE32013-102015-032015-03
NCT01931670A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated PainCOMPLETEDPHASE32013-09-092016-12-192016-01-06
NCT01958827A Study of Adalimumab After Dose Escalation in Japanese Subjects With Crohn's DiseaseCOMPLETEDPHASE32013-092015-102015-03
NCT01939197A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionCOMPLETEDPHASE2, PHASE32013-08-302016-10-252016-07-21
NCT01933919A Phase 3 Study of Fluvoxamine (SME3110) in Pediatric/Adolescent Patients With Obsessive Compulsive DisorderCOMPLETEDPHASE32013-08-142016-07-012015-06-18
NCT01946074A Study of ABT-165 in Subjects With Solid TumorsCOMPLETEDPHASE12013-08-082022-09-282022-09-28
NCT01853033A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-122 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE12013-072014-052014-05
NCT01908010Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsCOMPLETEDPHASE12013-072013-112013-11
NCT01889186A Study of the Efficacy of ABT-199 in Subjects With Relapsed/Refractory or Previously Untreated Chronic Lymphocytic Leukemia With the 17p DeletionCOMPLETEDPHASE22013-06-272020-12-152020-10-28
NCT01773070A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C StudyCOMPLETEDPHASE32013-062016-102016-10
NCT01854528A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) for Treatment of Chronic Hepatitis C Infection in Treatment-experienced AdultsCOMPLETEDPHASE32013-062015-072014-11
NCT01858532Study Of Diabetic Nephropathy With AtrasentanTERMINATEDPHASE32013-05-172018-03-292018-03-29
NCT01897519A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk SurgeryTERMINATEDPHASE22013-052014-052014-05
NCT01808118Continuing Versus Withdrawing Adalimumab in Maintaining Remission in Non-Radiographic Axial SpondyloarthritisCOMPLETEDPHASE32013-04-162017-04-142017-02-21
NCT01817530Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)COMPLETEDPHASE22013-04-082015-122015-06
NCT01800695Evaluating the Safety and Pharmacokinetics of ABT-414 for Subjects With Glioblastoma MultiformeCOMPLETEDPHASE12013-04-022017-06-192017-06-19
NCT01911845An Open-label, Single Arm, Phase 2 Study to Evaluate ABT-450/r/ABT-267 and ABT-333 With Ribavirin (RBV) in Adults With Genotype 1 HCV Infection Taking Methadone or BuprenorphineCOMPLETEDPHASE22013-042014-092013-12
NCT01853306A Study to Evaluate the Safety, Pharmacokinetics and Oral Bio Availability of Veliparib in Subjects With Solid TumorsCOMPLETEDPHASE12013-03-182017-06-292017-05-03
NCT01736176A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's DiseaseCOMPLETEDPHASE32013-032015-122015-03
NCT01833533A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1a InfectionCOMPLETEDPHASE32013-032014-092013-12
NCT01854697A Study to Evaluate the Efficacy and Safety of Three Experimental Drugs Compared With Telaprevir (a Licensed Product) in People With Hepatitis C Virus Infection Who Have Not Had Treatment BeforeCOMPLETEDPHASE32013-032015-072014-11
NCT01834638Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)TERMINATEDPHASE22013-032014-112014-11
NCT01782495A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant RecipientsCOMPLETEDPHASE22013-02-252017-07-132016-11-02
NCT01777165A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac SurgeryCOMPLETEDPHASE22013-022014-032014-03
NCT01760954Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated PainCOMPLETEDPHASE32012-12-282016-04-152015-05
NCT01609933A Study to Evaluate the Safety and Effect of Treatment With Experimental Antiviral Drugs in Combination With Peginterferon Alpha-2a and Ribavirin in People With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie/Abbott Combination StudyCOMPLETEDPHASE22012-12-182017-05-032017-05-03
NCT01767116A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b InfectionCOMPLETEDPHASE32012-122014-082013-12
NCT01752855Study in Rheumatoid Arthritis for Subjects Who Completed Preceding Study M13-390 With AdalimumabCOMPLETEDPHASE22012-122013-102013-10
NCT01794507A Study Evaluating ABT-199 in Multiple Myeloma Subjects Who Are Receiving Bortezomib and Dexamethasone as Standard TherapyCOMPLETEDPHASE12012-11-192019-07-162019-07-16
NCT01716585A Study to Evaluate Chronic Hepatitis C InfectionCOMPLETEDPHASE32012-112014-102013-10
NCT01715415A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced AdultsCOMPLETEDPHASE32012-112014-102013-11
NCT01686555A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ABT-199 in Female Patients With Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE12012-112015-062015-06
NCT01741493A Study in Healthy Adults and Adult Subjects With Rheumatoid Arthritis to Evaluate the Safety, Tolerability and Pharmacokinetics After Multiple Doses of ABT-494COMPLETEDPHASE12012-112013-122013-12
NCT01657799Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung CancerCOMPLETEDPHASE22012-10-192015-01-222015-01-22
NCT01794520Study Evaluating ABT-199 in Participants With Relapsed or Refractory Multiple MyelomaCOMPLETEDPHASE1, PHASE22012-10-102021-11-292021-11-29
NCT01704755A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated CirrhosisCOMPLETEDPHASE32012-102014-092014-01
NCT01741727A Study of ABT-414 in Subjects With Solid TumorsCOMPLETEDPHASE12012-102015-112015-11
NCT01690195Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseaseTERMINATEDPHASE22012-092014-022014-02
NCT01668511A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Subcutaneous Injections of ABT-981 in Patients With Osteoarthritis of the KneeCOMPLETEDPHASE12012-092013-102013-10
NCT01678755A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaCOMPLETEDPHASE22012-082014-032014-03
NCT01685203A Study to Evaluate the Safety and Effect of Co-administration of ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Adults With Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE22012-082015-022014-06
NCT01674725A Study to Evaluate the Safety and Effect of the Experimental Drugs ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 in Subjects With Chronic Hepatitis CCOMPLETEDPHASE32012-082014-102014-01
NCT01676935This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseaseTERMINATEDPHASE22012-082014-032014-03
NCT01646073Safety and Efficacy Study of Adalimumab in the Treatment of Plaque PsoriasisCOMPLETEDPHASE32012-082013-122013-12
NCT01682616A Phase 1b Study Evaluating the Safety and Tolerability of ABT-199 in Combination With Rituximab in Subjects With Relapsed Chronic Lymphocytic Leukemia and Small Lymphocytic LymphomaCOMPLETEDPHASE12012-07-252022-06-232022-06-23
NCT01672983A Study to Evaluate ABT-450 With Ritonavir (ABT-450/r) and ABT-267 in Japanese Adults With Chronic Hepatitis C Virus InfectionCOMPLETEDPHASE22012-072014-052014-05
NCT01589419A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal CancerCOMPLETEDPHASE12012-062015-012015-01
NCT01557777Open-label Extension Study of Navitoclax in Subjects With Chronic Lymphocytic Leukemia (CLL)COMPLETEDPHASE22012-062013-072013-07
NCT01712178A Study in Rheumatoid Arthritis (RA) Patients to Compare Two Formulations of Adalimumab for Pharmacokinetic, Pharmacodynamic and SafetyCOMPLETEDPHASE22012-062013-052013-05
NCT01620528A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated PainCOMPLETEDPHASE32012-05-222015-09-282014-11-14
NCT01594229A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaCOMPLETEDPHASE12012-05-212020-07-142020-07-14
NCT01506947A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant PatientsCOMPLETEDPHASE42012-05-102016-04-072016-04-07
NCT01655680A Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in SchizophreniaCOMPLETEDPHASE22012-052014-072014-04
NCT01550965A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice SettingCOMPLETEDPHASE32012-052015-042015-04
NCT01644396An Open-Label, Prospective Study to Assess the Safety and Effectiveness of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in the Russian FederationCOMPLETEDPHASE42012-052013-092013-09
NCT01617928A Study of Veliparib in Combination With Carboplatin and Paclitaxel in Japanese Subjects With Solid TumorsCOMPLETEDPHASE12012-052013-072013-07
NCT01635764Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis SuppurativaCOMPLETEDPHASE32012-042016-082016-08
NCT01577550Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe PsoriasisCOMPLETEDPHASE12012-042014-052013-10
NCT01579279A Study Comparing the Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic PainTERMINATEDPHASE22012-042012-052012-05
NCT01589432A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral NeuropathyCOMPLETEDPHASE22012-042012-112012-11
NCT01549834Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsCOMPLETEDPHASE22012-032013-102013-10
NCT01561313Crossover Study of Safety and Tolerability of Two Formulations of Adalimumab.COMPLETEDPHASE22012-032012-112012-11
NCT01560104A Clinical Study Conducted in Multiple Centers Comparing Veliparib in Combination With Carboplatin and Paclitaxel Versus a Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung CancerCOMPLETEDPHASE22012-022014-092014-09
NCT01563536Study to Assess the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ABT-267 in HCV Infected SubjectsCOMPLETEDPHASE22012-022013-062012-04
NCT01527916Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE22012-022013-112013-11
NCT01506609Study Evaluating Efficacy And Tolerability Of Veliparib in Combination With Temozolomide (TMZ) or In Combination With Carboplatin and Paclitaxel Versus Placebo in Participants With Breast Cancer Gene (BRCA)1 and BRCA2 Mutation and Metastatic Breast CancerCOMPLETEDPHASE22012-01-232020-09-022018-12-13
NCT01502423A Crossover Study of the Safety and Tolerability of Two Formulations of AdalimumabCOMPLETEDPHASE22012-012012-112012-11
NCT01741142Efficacy and Safety Study of ABT-436 in Major Depressive DisorderTERMINATEDPHASE22012-012015-082013-10
NCT01468207Efficacy and Safety Study of Adalimumab in Treatment of Hidradenitis SuppurativaCOMPLETEDPHASE32011-112014-012014-01
NCT01468233Efficacy and Safety Study of Adalimumab in the Treatment of Hidradenitis SuppurativaCOMPLETEDPHASE32011-112014-042014-04
NCT01472016Study of ABT-700 in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12011-10-062017-04-272017-04-27
NCT01406119An Extension Study of ABT-806 in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12011-102017-012017-01
NCT01382212A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCOMPLETEDPHASE32011-102015-042015-04
NCT01479127Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's DiseaseCOMPLETEDPHASE22011-102012-072012-07
NCT01464827ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected PatientsCOMPLETEDPHASE22011-102013-092013-03
NCT01444365A Study of ABT-652 in Combination With a Nonsteroidal Anti-Inflammatory Drug (NSAID) in Adults With Osteoarthritis Pain of the KneeCOMPLETEDPHASE22011-102012-042012-04
NCT01472003An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor TypesCOMPLETEDPHASE12011-102012-122012-12
NCT01441635Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine FibroidsCOMPLETEDPHASE22011-09-082014-05-172013-11
NCT01458535A Study to Evaluate Paritaprevir With Ritonavir (ABT-450/r) When Given Together With Ombitasvir and With and Without Ribavirin (RBV) in Treatment-NaĂŻve Participants With Genotype 1, 2 or 3 Chronic Hepatitis C Virus (HCV)COMPLETEDPHASE22011-092013-052013-05
NCT01424319Reducing Residual Albuminuria in Subjects With Diabetes and Nephropathy With AtrasentanCOMPLETEDPHASE22011-082012-072012-07
NCT01399580A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With NephropathyCOMPLETEDPHASE22011-082012-092012-09
NCT01466062Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical ConditionsCOMPLETEDPHASE32011-082012-042012-04
NCT01364922Phase 2 Chronic Low Back Pain StudyCOMPLETEDPHASE22011-062011-102011-10
NCT01403038An Open-label Study of the Effects of Elagolix in Adult Premenopausal FemalesCOMPLETEDPHASE12011-062012-112012-10
NCT01413893An Extension Study of Linifanib (ABT-869) in Subjects With Advanced or Metastatic Solid TumorsCOMPLETEDPHASE12011-062012-062012-06
NCT01380704Safety and Pharmacodynamic Study of ABT-436 in Major Depressive DisorderCOMPLETEDPHASE12011-062011-092011-09
NCT01328626A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin LymphomaCOMPLETEDPHASE12011-05-232020-05-082020-05-08
NCT01192568Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic BladderCOMPLETEDPHASE42011-05-172023-10-242023-08-29
NCT01339650Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal CancerCOMPLETEDPHASE12011-05-062017-11-302017-11-30
NCT01341782Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary HyperparathyroidismCOMPLETEDPHASE32011-052012-042012-04
NCT01333722Acute Pain Study Following BunionectomyCOMPLETEDPHASE22011-042011-062011-06
NCT01356849Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorCOMPLETEDPHASE22011-042012-082012-08
NCT01345045A Multicenter Study Comparing the Analgesic Effects and Safety of ABT-639 Compared to Placebo in Subjects With Diabetic Neuropathic PainCOMPLETEDPHASE22011-042011-102011-10
NCT01314261Study of ABT-267 in Treatment Naive Hepatitis C Virus (HCV) Genotype 1 Infected SubjectsCOMPLETEDPHASE22011-032013-022012-01
NCT01235689Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's DiseaseCOMPLETEDPHASE32011-02-112017-01-032016-11-03
NCT01306617A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-450 With Ritonavir (ABT-450/r) When Given Together With ABT-333 and Ribavirin (RBV) in Treatment-NaĂŻve and Non-responder Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE22011-022012-102011-11
NCT01251614A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. MethotrexateCOMPLETEDPHASE32010-122015-022013-12
NCT01148225A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitisCOMPLETEDPHASE32010-11-232018-05-212018-05-21
NCT01255657A Study of ABT-806 in Subjects With Advanced Solid Tumor TypesCOMPLETEDPHASE12010-112012-112012-11
NCT01221298A Pilot Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ABT-450 With Ritonavir (ABT-450/r) Dosed in Combination With ABT-072 and Ribavirin (RBV)COMPLETEDPHASE22010-102012-042011-05
NCT01243671A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's DiseaseCOMPLETEDPHASE32010-102013-062012-03
NCT01185301Study to Determine the Effects of Different Doses of Methotrexate (MTX) When Taken With Adalimumab in Subjects With Early Rheumatoid Arthritis (RA)COMPLETEDPHASE32010-102012-092012-09
NCT01265823Immediate Response With Adalimumab and Its Impact on Quality of Life and Other Comorbidity Factors in Patients With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE42010-102012-022012-02
NCT01166282A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related ArthritisCOMPLETEDPHASE32010-092015-122012-11
NCT01162421A Canadian Study to Evaluate Early Use of Adalimumab After Methotrexate Failure in Early Rheumatoid ArthritisCOMPLETEDPHASE42010-092015-072015-07
NCT01185288A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With Adalimumab (MUSICA)COMPLETEDPHASE42010-092013-012013-01
NCT01207115A Study of ABT-652 in Adults With Osteoarthritis Pain of the KneeCOMPLETEDPHASE22010-092011-052011-05
NCT01225302A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE12010-092012-062012-06
NCT01138657Efficacy and Safety of Adalimumab in Patients With Active UveitisCOMPLETEDPHASE32010-082014-082014-07
NCT01124838Efficacy and Safety of Adalimumab in Subjects With Inactive UveitisCOMPLETEDPHASE32010-082015-052015-05
NCT01199224To Determine the Food Effect and Bioavailability of Three Formulations of Veliparib in Subjects With Solid TumorsCOMPLETEDPHASE12010-062010-112010-11
NCT01163617The Usability and Injection Time of the Physiolis Syringe and Autoinjector in Rheumatoid Arthritis PatientsCOMPLETEDPHASE22010-052010-112010-11
NCT01137526Efficacy and Safety Study of ABT-384 in Subjects With Mild-to-Moderate Alzheimer's DiseaseCOMPLETEDPHASE22010-052011-072011-07
NCT01133548Pharmacokinetic and Comparative Bioavailability Study of Testosterone Absorption After Administration of Testosterone Gel 1.62% to the Upper Arms/Shoulders Using an Application Site Rotation or a Combination of Application Sites in Hypogonadal MalesCOMPLETEDPHASE12010-052010-072010-07
NCT01130298An Open-Label Study of Serum Testosterone Levels in Non-dosed Females After Secondary Exposure to Testosterone Gel 1.62% Applied to the Upper Arms and Shoulders and Use of a T-shirt BarrierCOMPLETEDPHASE12010-052010-052010-05
NCT01121133A Study to Assess the Effect of Rifampin on the Metabolism of NavitoclaxCOMPLETEDPHASE12010-052011-052011-05
NCT01110473ABT-348 as Monotherapy and in Combination With Azacitidine to Treat Advanced Hematologic MalignanciesCOMPLETEDPHASE12010-042013-062013-06
NCT01085422A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate CancerCOMPLETEDPHASE12010-042011-062011-06
NCT01484990A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's DiseaseCOMPLETEDPHASE12010-042010-092010-09
NCT01123876Evaluating the Safety and Tolerability of the Poly-ADP Ribose (PARP) Inhibitor With FOLFIRI in Subjects With Solid TumorCOMPLETEDPHASE12010-032015-012015-01
NCT01074008A Randomized Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072COMPLETEDPHASE22010-032012-012011-06
NCT01113957A Trial of ABT-888 in Combination With Temozolomide Versus Pegylated Liposomal Doxorubicin Alone in Ovarian CancerCOMPLETEDPHASE22010-032013-062013-06
NCT01110486ABT-348 as Monotherapy or Combination With Carboplatin or Docetaxel to Treat Advanced Solid TumorsCOMPLETEDPHASE12010-032013-092013-09
NCT01095562Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With SchizophreniaCOMPLETEDPHASE22010-032011-092011-08
NCT01077700Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With SchizophreniaCOMPLETEDPHASE22010-032011-072011-07
NCT01064856Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)COMPLETEDPHASE32010-022014-052011-08
NCT01020487Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)COMPLETEDPHASE32010-022014-122014-05
NCT01063816A Study of ABT-888 in Combination With Carboplatin and Gemcitabine in Subjects With Advanced Solid TumorsCOMPLETEDPHASE12010-012016-082016-08
NCT00660387Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsCOMPLETEDPHASE32009-122011-102011-10
NCT01038609Hydrocodone/Acetaminophen for Acute Pain Following BunionectomyCOMPLETEDPHASE22009-122010-052010-05
NCT01018875Efficacy and Safety Study of ABT-288 in Subjects With Mild-to-Moderate Alzheimer's DiseaseCOMPLETEDPHASE22009-122011-022011-02
NCT00660673Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's DiseaseCOMPLETEDPHASE32009-11-132021-11-302021-11-30
NCT00868413Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic LeukemiaCOMPLETEDPHASE12009-112013-052013-05
NCT00973973Efficacy and Safety Study of Elagolix in Women With EndometriosisCOMPLETEDPHASE22009-10-122010-09-222010-09-22
NCT01009073A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsCOMPLETEDPHASE12009-102013-062013-06
NCT00948909Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's DiseaseCOMPLETEDPHASE22009-102010-112010-11
NCT00878449A Study Evaluating the Safety of ABT-263 in Combination With Etoposide/Cisplatin in Subjects With CancerCOMPLETEDPHASE12009-102011-072011-07
NCT00986037Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With AsthmaCOMPLETEDPHASE12009-102010-07
NCT00982566Assess the Oral Bioavailability of a New ABT-263 Formulation in Subjects With CancerCOMPLETEDPHASE12009-102010-122010-10
NCT00887757Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid TumorsCOMPLETEDPHASE12009-092011-112011-11
NCT00788684Safety Study of ABT-263 in Combination With Rituximab in Lymphoid CancersCOMPLETEDPHASE12009-07-212025-02-072025-02-07
NCT00939003Study of Adalimumab in Patients With Axial SpondyloarthritisCOMPLETEDPHASE32009-072013-082011-02
NCT00891605Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid TumorsCOMPLETEDPHASE12009-072012-072012-07
NCT00360568Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's SubjectsCOMPLETEDPHASE32009-062012-102012-10
NCT00935311Hydrocodone/Acetaminophen for Acute Pain Following Third Molar Tooth ExtractionCOMPLETEDPHASE22009-062009-082009-08
NCT00920764A Study of Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System InhibitorsCOMPLETEDPHASE22009-062010-052010-04
NCT00872196A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 StudiesCOMPLETEDPHASE22009-042010-042010-04
NCT00775437Active Juvenile Idiopathic Arthritis (JIA) Compassionate UseCOMPLETEDPHASE32009-032013-032013-03
NCT00851890A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Multiple Doses of ABT-333 Alone and in Combination With Pegylated Interferon (pegIFN) and Ribavirin (RBV) in Subjects With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCOMPLETEDPHASE22009-032009-072009-07
NCT00804908A Study Evaluating Efficacy of ABT-888 in Combination With Temozolomide in Metastatic MelanomaCOMPLETEDPHASE22009-022016-012016-01
NCT00853099A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative ColitisCOMPLETEDPHASE32009-022013-082011-05
NCT00733187Pharmacokinetic Study To Evaluate Effect of Food and Diurnal Variation on ABT-869COMPLETEDPHASE12009-022012-062012-06
NCT00850044Safety, Tolerability and PK Study of Single Doses of ABT-450 With and Without Ritonavir to Treat Hepatitis C Virus (HCV) Genotype 1COMPLETEDPHASE12009-022009-07
NCT00357994Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's SubjectsCOMPLETEDPHASE32009-012011-102011-10
NCT00808509A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical RemissionCOMPLETEDPHASE42009-012012-092012-09
NCT00667446Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious PubertyCOMPLETEDPHASE32008-122013-012012-10
NCT00797225Efficacy and Safety Study of Elagolix Versus Placebo or Leuprorelin Acetate in EndometriosisCOMPLETEDPHASE22008-11-262010-02-242010-02-24
NCT00888693A Multiple Dose Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-288 in Stable Subjects With SchizophreniaCOMPLETEDPHASE12008-112009-12
NCT00707889Phase 2 Study of ABT-869 in Combination With mFOLFOX6 Versus Bevacizumab in Combination With mFOLFOX6 to Treat Advanced Colorectal CancerCOMPLETEDPHASE22008-102012-052012-05
NCT00761150Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)COMPLETEDPHASE32008-092009-032009-03
NCT00763321Study to Evaluate the Safety and Efficacy of ABT-712 in Subjects With Moderate to Severe Chronic Low Back Pain (CLBP)COMPLETEDPHASE32008-092009-042009-04
NCT00718380A Phase 1 Study of ABT-869 in Subjects With Solid TumorsCOMPLETEDPHASE12008-092012-062012-06
NCT00742560A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple MyelomaCOMPLETEDPHASE22008-082016-102016-10
NCT00726882A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 StudiesCOMPLETEDPHASE22008-082010-052010-05
NCT00710580Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE32008-072009-042009-04
NCT00645177Phase 2 Study of ABT-869 in Combination With Paclitaxel Versus Paclitaxel Alone to Treat Metastatic Breast CancerCOMPLETEDPHASE22008-072009-122009-12
NCT00716534Study of Carboplatin/Paclitaxel in Combination With ABT-869 in Subjects With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22008-062012-042012-04
NCT00696904Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected SubjectsCOMPLETEDPHASE12008-062009-02
NCT00686374Efficacy and Long Term Safety of Adalimumab in Pediatric Subjects Who Have Demonstrated Clinical Response in M06-806COMPLETEDPHASE32008-05-012017-04-042017-04-04
NCT00691964Study Comparing the Efficacy and Safety of ABT-874 to Etanercept and Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE32008-052009-032009-03
NCT00686933Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22008-052008-102008-10
NCT00679731A Study of Safety and Efficacy Comparing ABT-874 Versus Methotrexate in Subjects With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE32008-042009-112009-11
NCT00649207A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain MetastasesCOMPLETEDPHASE12008-032013-032013-03
NCT00640419Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22008-032008-072008-07
NCT00640185Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22008-032008-082008-08
NCT00619866An Efficacy and Safety Study of Elagolix (NBI-56418) in Women With EndometriosisCOMPLETEDPHASE22008-02-192009-08-282009-04-20
NCT00616772Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the BloodCOMPLETEDPHASE32008-022012-092012-09
NCT00497146The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4COMPLETEDPHASE32008-022012-032010-09
NCT00626002Open Label Continuation Study in Moderate to Severe PsoriasisCOMPLETEDPHASE32008-022011-102011-10
NCT00335153Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's DiseaseCOMPLETEDPHASE32008-012012-062012-06
NCT00654758A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE12007-122010-052010-05
NCT00573794Long-term Open-label Safety and Efficacy Study of Adalimumab in Subjects With Ulcerative ColitisCOMPLETEDPHASE32007-11-282016-122016-12
NCT00570986A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE32007-112009-062009-06
NCT00548925A Safety and Efficacy Study in Subjects With Diabetic Neuropathic PainCOMPLETEDPHASE22007-112008-122008-12
NCT00517920Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)COMPLETEDPHASE22007-092012-062011-06
NCT00528697A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22007-092008-042008-04
NCT00507936Safety and Efficacy Study in Subjects With Diabetic Neuropathic PainCOMPLETEDPHASE22007-082008-102008-10
NCT00517790Study of ABT-869 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22007-082012-062011-06
NCT00526617A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer PatientsCOMPLETEDPHASE12007-082010-06
NCT00481091A Study of ABT-263 in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaCOMPLETEDPHASE1, PHASE22007-07-252022-05-122022-05-12
NCT00635193Efficacy and Safety Study of M200(Volociximab in Combination With Liposomal Doxorubicin)COMPLETEDPHASE1, PHASE22007-072009-102008-10
NCT00486538Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With SunitinibCOMPLETEDPHASE22007-062012-062011-06
NCT00650156Pharmacokinetic and Safety Study With Adalimumab in Chinese Subjects With Mild Rheumatoid ArthritisCOMPLETEDPHASE12007-062007-10
NCT00445198A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological MalignanciesCOMPLETEDPHASE1, PHASE22007-042010-122010-12
NCT00443391A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)COMPLETEDPHASE22007-022008-102008-10
NCT00437658Elagolix Versus Subcutaneous Depot Medroxyprogesterone Acetate for the Treatment of EndometriosisCOMPLETEDPHASE22006-12-112008-11-242008-11-24
NCT00406809A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid MalignanciesCOMPLETEDPHASE1, PHASE22006-112016-102016-10
NCT00297089A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung CancerCOMPLETEDPHASE1, PHASE22006-112009-012009-01
NCT00141518Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic ImpactCOMPLETEDPHASE42006-032011-042011-03
NCT00292396Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque PsoriasisCOMPLETEDPHASE22005-112008-042008-04
NCT00401570A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic CancerCOMPLETEDPHASE22005-032008-062008-06
NCT00086671Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)COMPLETEDPHASE22004-042006-112006-11
NCT00648999Safety and Efficacy of Kaletra in ARV Therapy Experienced PatientsCOMPLETEDPHASE42003-112006-122006-12
NCT00234975Safety of Lopinavir/Ritonavir (Kaletra) in HIV/HCV Co-infected Subjects vs Baseline Liver Biopsy Metavir ScoreCOMPLETEDPHASE42002-102008-012008-01
NCT00195663Efficacy and Safety of Adalimumab and Methotrexate (MTX) Versus MTX Monotherapy in Subjects With Early Rheumatoid ArthritisCOMPLETEDPHASE32000-122012-042004-04